% Generated by Paperpile. Check out https://paperpile.com for more information.
% BibTeX export options can be customized via Settings -> BibTeX.

@ARTICLE{Demetriou2013-wb,
  title    = "Methylome analysis and epigenetic changes associated with
              menarcheal age",
  author   = "Demetriou, Christiana A and Chen, Jia and Polidoro, Silvia and
              van Veldhoven, Karin and Cuenin, Cyrille and Campanella, Gianluca
              and Brennan, Kevin and Clavel-Chapelon, Fran{\c c}oise and
              Dossus, Laure and Kvaskoff, Marina and Drogan, Dagmar and Boeing,
              Heiner and Kaaks, Rudolf and Risch, Angela and Trichopoulos,
              Dimitrios and Lagiou, Pagona and Masala, Giovanna and Sieri,
              Sabina and Tumino, Rosario and Panico, Salvatore and Quir{\'o}s,
              J Ram{\'o}n and S{\'a}nchez Perez, Mar{\'\i}a-Jos{\'e} and
              Amiano, Pilar and Huerta Casta{\~n}o, Jos{\'e} Mar{\'\i}a and
              Ardanaz, Eva and Onland-Moret, Charlotte and Peeters, Petra and
              Khaw, Kay-Tee and Wareham, Nick and Key, Timothy J and Travis,
              Ruth C and Romieu, Isabelle and Gallo, Valentina and Gunter, Marc
              and Herceg, Zdenko and Kyriacou, Kyriacos and Riboli, Elio and
              Flanagan, James M and Vineis, Paolo",
  abstract = "Reproductive factors have been linked to both breast cancer and
              DNA methylation, suggesting methylation as an important mechanism
              by which reproductive factors impact on disease risk. However,
              few studies have investigated the link between reproductive
              factors and DNA methylation in humans. Genome-wide methylation in
              peripheral blood lymphocytes of 376 healthy women from the
              prospective EPIC study was investigated using LUminometric
              Methylation Assay (LUMA). Also, methylation of 458877 CpG sites
              was additionally investigated in an independent group of 332
              participants of the EPIC-Italy sub-cohort, using the Infinium
              HumanMethylation 450 BeadChip. Multivariate logistic regression
              and linear models were used to investigate the association
              between reproductive risk factors and genome wide and
              CpG-specific DNA methylation, respectively. Menarcheal age was
              inversely associated with global DNA methylation as measured with
              LUMA. For each yearly increase in age at menarche, the risk of
              having genome wide methylation below median level was increased
              by 32\% (OR:1.32, 95\%CI:1.14-1.53). When age at menarche was
              treated as a categorical variable, there was an inverse
              dose-response relationship with LUMA methylation levels (OR(12-14
              vs. $\leq$11 yrs):1.78, 95\%CI:1.01-3.17 and OR($\geq$15 vs.
              $\leq$11 yrs):4.59, 95\%CI:2.04-10.33; P for trend<0.0001).
              However, average levels of global methylation as measured by the
              Illumina technology were not significantly associated with
              menarcheal age. In locus by locus comparative analyses, only one
              CpG site had significantly different methylation depending on the
              menarcheal age category examined, but this finding was not
              replicated by pyrosequencing in an independent data set. This
              study suggests a link between age at menarche and genome wide DNA
              methylation, and the difference in results between the two arrays
              suggests that repetitive element methylation has a role in the
              association. Epigenetic changes may be modulated by menarcheal
              age, or the association may be a mirror of other important
              changes in early life that have a detectable effect on both
              methylation levels and menarcheal age.",
  journal  = "PLoS One",
  volume   =  8,
  number   =  11,
  pages    = "e79391",
  month    =  nov,
  year     =  2013,
  language = "en"
}

@BOOK{McKinney2012-ta,
  title     = "Python for Data Analysis: Data Wrangling with Pandas, {NumPy},
               and {IPython}",
  author    = "McKinney, Wes",
  abstract  = "Python for Data Analysis is concerned with the nuts and bolts of
               manipulating, processing, cleaning, and crunching data in
               Python. It is also a practical, modern introduction to
               scientific computing in Python, tailored for data-intensive
               applications. This is a book about the parts of the Python
               language and libraries you'll need to effectively solve a broad
               set of data analysis problems. This book is not an exposition on
               analytical methods using Python as the implementation
               language.Written by Wes McKinney, the main author of the pandas
               library, this hands-on book is packed with practical cases
               studies. It's ideal for analysts new to Python and for Python
               programmers new to scientific computing.Use the IPython
               interactive shell as your primary development environmentLearn
               basic and advanced NumPy (Numerical Python) featuresGet started
               with data analysis tools in the pandas libraryUse
               high-performance tools to load, clean, transform, merge, and
               reshape dataCreate scatter plots and static or interactive
               visualizations with matplotlibApply the pandas groupby facility
               to slice, dice, and summarize datasetsMeasure data by points in
               time, whether it's specific instances, fixed periods, or
               intervalsLearn how to solve problems in web analytics, social
               sciences, finance, and economics, through detailed examples",
  publisher = "``O'Reilly Media, Inc.''",
  month     =  oct,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Layer2018-gr,
  title    = "{GIGGLE}: a search engine for large-scale integrated genome
              analysis",
  author   = "Layer, Ryan M and Pedersen, Brent S and DiSera, Tonya and Marth,
              Gabor T and Gertz, Jason and Quinlan, Aaron R",
  abstract = "GIGGLE is a genomics search engine that identifies and ranks the
              significance of genomic loci shared between query features and
              thousands of genome interval files. GIGGLE
              (https://github.com/ryanlayer/giggle) scales to billions of
              intervals and is over three orders of magnitude faster than
              existing methods. Its speed extends the accessibility and utility
              of resources such as ENCODE, Roadmap Epigenomics, and GTEx by
              facilitating data integration and hypothesis generation.",
  journal  = "Nat. Methods",
  volume   =  15,
  number   =  2,
  pages    = "123--126",
  month    =  feb,
  year     =  2018,
  language = "en"
}

@ARTICLE{Bujold2016-vk,
  title    = "The International Human Epigenome Consortium Data Portal",
  author   = "Bujold, David and Morais, David Anderson de Lima and Gauthier,
              Carol and C{\^o}t{\'e}, Catherine and Caron, Maxime and Kwan,
              Tony and Chen, Kuang Chung and Laperle, Jonathan and Markovits,
              Alexei Nordell and Pastinen, Tomi and Caron, Bryan and Veilleux,
              Alain and Jacques, Pierre-{\'E}tienne and Bourque, Guillaume",
  abstract = "The International Human Epigenome Consortium (IHEC) coordinates
              the production of reference epigenome maps through the
              characterization of the regulome, methylome, and transcriptome
              from a wide range of tissues and cell types. To define
              conventions ensuring the compatibility of datasets and establish
              an infrastructure enabling data integration, analysis, and
              sharing, we developed the IHEC Data Portal
              (http://epigenomesportal.ca/ihec). The portal provides access to
              >7,000 reference epigenomic datasets, generated from >600
              tissues, which have been contributed by seven international
              consortia: ENCODE, NIH Roadmap, CEEHRC, Blueprint, DEEP,
              AMED-CREST, and KNIH. The portal enhances the utility of these
              reference maps by facilitating the discovery, visualization,
              analysis, download, and sharing of epigenomics data. The IHEC
              Data Portal is the official source to navigate through IHEC
              datasets and represents a strategy for unifying the distributed
              data produced by international research consortia.",
  journal  = "Cell Syst",
  volume   =  3,
  number   =  5,
  pages    = "496--499.e2",
  month    =  nov,
  year     =  2016,
  keywords = "API; IHEC; accession; analysis; archival; dataset; epigenomics;
              metadata; online resource; portal; visualization",
  language = "en"
}

@ARTICLE{Ramirez2016-xl,
  title    = "deepTools2: a next generation web server for deep-sequencing data
              analysis",
  author   = "Ram{\'\i}rez, Fidel and Ryan, Devon P and Gr{\"u}ning, Bj{\"o}rn
              and Bhardwaj, Vivek and Kilpert, Fabian and Richter, Andreas S
              and Heyne, Steffen and D{\"u}ndar, Friederike and Manke, Thomas",
  abstract = "We present an update to our Galaxy-based web server for
              processing and visualizing deeply sequenced data. Its core tool
              set, deepTools, allows users to perform complete bioinformatic
              workflows ranging from quality controls and normalizations of
              aligned reads to integrative analyses, including clustering and
              visualization approaches. Since we first described our deepTools
              Galaxy server in 2014, we have implemented new solutions for many
              requests from the community and our users. Here, we introduce
              significant enhancements and new tools to further improve data
              visualization and interpretation. deepTools continue to be open
              to all users and freely available as a web service at
              deeptools.ie-freiburg.mpg.de The new deepTools2 suite can be
              easily deployed within any Galaxy framework via the toolshed
              repository, and we also provide source code for command line
              usage under Linux and Mac OS X. A public and documented API for
              access to deepTools functionality is also available.",
  journal  = "Nucleic Acids Res.",
  volume   =  44,
  number   = "W1",
  pages    = "W160--5",
  month    =  jul,
  year     =  2016,
  language = "en"
}

@ARTICLE{Robinson2011-he,
  title    = "Integrative genomics viewer",
  author   = "Robinson, James T and Thorvaldsd{\'o}ttir, Helga and Winckler,
              Wendy and Guttman, Mitchell and Lander, Eric S and Getz, Gad and
              Mesirov, Jill P",
  journal  = "Nat. Biotechnol.",
  volume   =  29,
  number   =  1,
  pages    = "24--26",
  month    =  jan,
  year     =  2011,
  language = "en"
}

@ARTICLE{Horvath2018-ia,
  title    = "{DNA} methylation-based biomarkers and the epigenetic clock
              theory of ageing",
  author   = "Horvath, Steve and Raj, Kenneth",
  abstract = "Identifying and validating molecular targets of interventions
              that extend the human health span and lifespan has been
              difficult, as most clinical biomarkers are not sufficiently
              representative of the fundamental mechanisms of ageing to serve
              as their indicators. In a recent breakthrough, biomarkers of
              ageing based on DNA methylation data have enabled accurate age
              estimates for any tissue across the entire life course. These
              'epigenetic clocks' link developmental and maintenance processes
              to biological ageing, giving rise to a unified theory of life
              course. Epigenetic biomarkers may help to address long-standing
              questions in many fields, including the central question: why do
              we age?",
  journal  = "Nat. Rev. Genet.",
  volume   =  19,
  number   =  6,
  pages    = "371--384",
  month    =  jun,
  year     =  2018,
  language = "en"
}

@ARTICLE{Coulson2005-pb,
  title    = "Transcriptional regulation: cancer, neurons and the {REST}",
  author   = "Coulson, Judy M",
  abstract = "REST/NRSF was first identified as a transcriptional repressor of
              neuronal genes in non-neuronal cells. Recent studies have now
              revealed seemingly paradoxical roles for REST/NRSF in
              neurogenesis, neural plasticity, tumour suppression and cancer
              progression.",
  journal  = "Curr. Biol.",
  volume   =  15,
  number   =  17,
  pages    = "R665--8",
  month    =  sep,
  year     =  2005,
  language = "en"
}

@ARTICLE{Huang2019-hf,
  title    = "Epigenetic Age Acceleration in Adolescence Associates With {BMI},
              Inflammation, and Risk Score for Middle Age Cardiovascular
              Disease",
  author   = "Huang, Rae-Chi and Lillycrop, Karen A and Beilin, Lawrence J and
              Godfrey, Keith M and Anderson, Denise and Mori, Trevor A and
              Rauschert, Sebastian and Craig, Jeffrey M and Oddy, Wendy H and
              Ayonrinde, Oyekoya T and Pennell, Craig E and Holbrook, Joanna D
              and Melton, Phillip E",
  abstract = "CONTEXT: ``Accelerated aging,'' assessed by adult DNA
              methylation, predicts cardiovascular disease (CVD). Adolescent
              accelerated aging might predict CVD earlier. We investigated
              whether epigenetic age acceleration (assessed age, 17 years) was
              associated with adiposity/CVD risk measured (ages 17, 20, and 22
              years) and projected CVD by middle age. DESIGN: DNA methylation
              measured in peripheral blood provided two estimates of epigenetic
              age acceleration: intrinsic (IEAA; preserved across cell types)
              and extrinsic (EEAA; dependent on cell admixture and methylation
              levels within each cell type). Adiposity was assessed by
              anthropometry, ultrasound, and dual-energy x-ray absorptiometry
              (ages 17, 20, and 22 years). CVD risk factors [lipids,
              homeostatic model assessment of insulin resistance (HOMA-IR),
              blood pressure, inflammatory markers] were assessed at age 17
              years. CVD development by age 47 years was calculated by
              Framingham algorithms. Results are presented as regression
              coefficients per 5-year epigenetic age acceleration (IEAA/EEAA)
              for adiposity, CVD risk factors, and CVD development. RESULTS: In
              995 participants (49.6\% female; age, 17.3 $\pm$ 0.6 years), EEAA
              (per 5 years) was associated with increased body mass index (BMI)
              of 2.4\% (95\% CI, 1.2\% to 3.6\%) and 2.4\% (0.8\% to 3.9\%) at
              17 and 22 years, respectively. EEAA was associated with increases
              of 23\% (3\% to 33\%) in high-sensitivity C-reactive protein,
              10\% (4\% to 17\%) in interferon-$\gamma$-inducible protein of 10
              kDa, and 4\% (2\% to 6\%) in soluble TNF receptor 2, adjusted for
              BMI and HOMA-IR. EEAA (per 5 years) results in a 4\% increase in
              hard endpoints of CVD by 47 years of age and a 3\% increase,
              after adjustment for conventional risk factors. CONCLUSIONS:
              Accelerated epigenetic age in adolescence was associated with
              inflammation, BMI measured 5 years later, and probability of
              middle age CVD. Irrespective of whether this is cause or effect,
              assessing epigenetic age might refine disease prediction.",
  journal  = "J. Clin. Endocrinol. Metab.",
  volume   =  104,
  number   =  7,
  pages    = "3012--3024",
  month    =  jul,
  year     =  2019,
  language = "en"
}

@MISC{Liu2013-dg,
  title   = "Epigenome-wide association data implicate {DNA} methylation as an
             intermediary of genetic risk in rheumatoid arthritis",
  author  = "Liu, Yun and Aryee, Martin J and Padyukov, Leonid and Daniele
             Fallin, M and Hesselberg, Espen and Runarsson, Arni and Reinius,
             Lovisa and Acevedo, Nathalie and Taub, Margaret and Ronninger,
             Marcus and Shchetynsky, Klementy and Scheynius, Annika and Kere,
             Juha and Alfredsson, Lars and Klareskog, Lars and Ekstr{\"o}m,
             Tomas J and Feinberg, Andrew P",
  journal = "Nature Biotechnology",
  volume  =  31,
  number  =  2,
  pages   = "142--147",
  year    =  2013
}

@ARTICLE{Tharakan2020-pj,
  title    = "Blood {DNA} Methylation and Aging: A {Cross-Sectional} Analysis
              and Longitudinal Validation in the {InCHIANTI} Study",
  author   = "Tharakan, Ravi and Ubaida-Mohien, Ceereena and Moore, Ann Zenobia
              and Hernandez, Dena and Tanaka, Toshiko and Ferrucci, Luigi",
  abstract = "Changes in DNA methylation have been found to be highly
              correlated with aging in humans, but causes or consequences of
              these changes are not understood. We characterized the DNA
              methylomes of several hundred people in the Invecchiare in
              Chianti study to identify DNA sites in which percent methylation
              was systematically different with age. Then, we tested the
              hypothesis that changes of percent methylation in the same DNA
              sites occur longitudinally for the same DNA sites in the same
              subjects. We identified six differentially methylated regions in
              which percent methylation showed robust longitudinal changes in
              the same direction. We then describe functions of the genes near
              these differentially methylated regions and their potential
              relationship with aging, noting that the genes appear to regulate
              metabolism or cell type specificity. The nature of transcription
              factor binding sites in the vicinity of these differentially
              methylated regions suggest that these age-associated methylation
              changes reflect modulation of two biological mechanisms: the
              polycomb repressive complex 2, a protein complex that
              trimethylates histone H3 on lysine 27, and the transcriptional
              repressor CCCTC-binding factor or CTCF, both of which are
              regulators of chromatin architecture. These findings are
              consistent with the idea that changes in methylation with aging
              are of adaptive nature.",
  journal  = "J. Gerontol. A Biol. Sci. Med. Sci.",
  volume   =  75,
  number   =  11,
  pages    = "2051--2055",
  month    =  oct,
  year     =  2020,
  keywords = "DNA methylation; Epigenetics; Epigenetics of aging; Epigenomics;
              Longitudinal epigenomics",
  language = "en"
}

@ARTICLE{Triche2013-pp,
  title    = "Low-level processing of Illumina Infinium {DNA} Methylation
              {BeadArrays}",
  author   = "Triche, Jr, Timothy J and Weisenberger, Daniel J and Van Den
              Berg, David and Laird, Peter W and Siegmund, Kimberly D",
  abstract = "We propose a novel approach to background correction for Infinium
              HumanMethylation data to account for technical variation in
              background fluorescence signal. Our approach capitalizes on a new
              use for the Infinium I design bead types to measure non-specific
              fluorescence in the colour channel opposite of their design
              (Cy3/Cy5). This provides tens of thousands of features for
              measuring background instead of the much smaller number of
              negative control probes on the platforms (n = 32 for
              HumanMethylation27 and n = 614 for HumanMethylation450,
              respectively). We compare the performance of our methods with
              existing approaches, using technical replicates of both mixture
              samples and biological samples, and demonstrate that within- and
              between-platform artefacts can be substantially reduced, with
              concomitant improvement in sensitivity, by the proposed methods.",
  journal  = "Nucleic Acids Res.",
  volume   =  41,
  number   =  7,
  pages    = "e90",
  month    =  apr,
  year     =  2013,
  language = "en"
}

@ARTICLE{Lopes-Ramos2020-ex,
  title    = "Sex Differences in Gene Expression and Regulatory Networks across
              29 Human Tissues",
  author   = "Lopes-Ramos, Camila M and Chen, Cho-Yi and Kuijjer, Marieke L and
              Paulson, Joseph N and Sonawane, Abhijeet R and Fagny, Maud and
              Platig, John and Glass, Kimberly and Quackenbush, John and DeMeo,
              Dawn L",
  abstract = "Sex differences manifest in many diseases and may drive
              sex-specific therapeutic responses. To understand the molecular
              basis of sex differences, we evaluated sex-biased gene regulation
              by constructing sample-specific gene regulatory networks in 29
              human healthy tissues using 8,279 whole-genome expression
              profiles from the Genotype-Tissue Expression (GTEx) project. We
              find sex-biased regulatory network structures in each tissue.
              Even though most transcription factors (TFs) are not
              differentially expressed between males and females, many have
              sex-biased regulatory targeting patterns. In each tissue, genes
              that are differentially targeted by TFs between the sexes are
              enriched for tissue-related functions and diseases. In brain
              tissue, for example, genes associated with Parkinson's disease
              and Alzheimer's disease are targeted by different sets of TFs in
              each sex. Our systems-based analysis identifies a repertoire of
              TFs that play important roles in sex-specific architecture of
              gene regulatory networks, and it underlines sex-specific
              regulatory processes in both health and disease.",
  journal  = "Cell Rep.",
  volume   =  31,
  number   =  12,
  pages    = "107795",
  month    =  jun,
  year     =  2020,
  keywords = "GTEx; differential expression; differential targeting; gender;
              gene regulation; gene regulatory networks; sex differences;
              sexual dimorphism",
  language = "en"
}

@ARTICLE{Theilgaard-Monch2022-zw,
  title    = "Transcription factor-driven coordination of cell cycle exit and
              lineage-specification in vivo during granulocytic differentiation
              : In memoriam Professor Niels Borregaard",
  author   = "Theilgaard-M{\"o}nch, Kim and Pundhir, Sachin and Reckzeh,
              Kristian and Su, Jinyu and Tapia, Marta and Furtw{\"a}ngler,
              Benjamin and Jendholm, Johan and Jakobsen, Janus Schou and
              Hasemann, Marie Sigurd and Knudsen, Kasper Jermiin and Cowland,
              Jack Bernard and Fossum, Anna and Schoof, Erwin and Schuster,
              Mikkel Bruhn and Porse, Bo T",
  abstract = "Differentiation of multipotent stem cells into mature cells is
              fundamental for development and homeostasis of mammalian tissues,
              and requires the coordinated induction of lineage-specific
              transcriptional programs and cell cycle withdrawal. To understand
              the underlying regulatory mechanisms of this fundamental process,
              we investigated how the tissue-specific transcription factors,
              CEBPA and CEBPE, coordinate cell cycle exit and
              lineage-specification in vivo during granulocytic
              differentiation. We demonstrate that CEBPA promotes
              lineage-specification by launching an enhancer-primed
              differentiation program and direct activation of CEBPE
              expression. Subsequently, CEBPE confers promoter-driven cell
              cycle exit by sequential repression of MYC target gene expression
              at the G1/S transition and E2F-meditated G2/M gene expression, as
              well as by the up-regulation of Cdk1/2/4 inhibitors. Following
              cell cycle exit, CEBPE unleashes the CEBPA-primed differentiation
              program to generate mature granulocytes. These findings highlight
              how tissue-specific transcription factors coordinate cell cycle
              exit with differentiation through the use of distinct gene
              regulatory elements.",
  journal  = "Nat. Commun.",
  volume   =  13,
  number   =  1,
  pages    = "3595",
  month    =  jun,
  year     =  2022,
  language = "en"
}

@ARTICLE{Kurushima2019-pe,
  title    = "Epigenetic findings in periodontitis in {UK} twins: a
              cross-sectional study",
  author   = "Kurushima, Yuko and Tsai, Pei-Chien and Castillo-Fernandez, Juan
              and Couto Alves, Alexessander and El-Sayed Moustafa, Julia Sarah
              and Le Roy, Caroline and Spector, Tim D and Ide, Mark and Hughes,
              Francis J and Small, Kerrin S and Steves, Claire J and Bell,
              Jordana T",
  abstract = "BACKGROUND: Genetic and environmental risk factors contribute to
              periodontal disease, but the underlying susceptibility pathways
              are not fully understood. Epigenetic mechanisms are malleable
              regulators of gene function that can change in response to
              genetic and environmental stimuli, thereby providing a potential
              mechanism for mediating risk effects in periodontitis. The aim of
              this study is to identify epigenetic changes across tissues that
              are associated with periodontal disease. METHODS: Self-reported
              gingival bleeding and history of gum disease, or tooth mobility,
              were used as indicators of periodontal disease. DNA methylation
              profiles were generated using the Infinium HumanMethylation450
              BeadChip in whole blood, buccal, and adipose tissue samples from
              predominantly older female twins (mean age 58) from the TwinsUK
              cohort. Epigenome-wide association scans (EWAS) of gingival
              bleeding and tooth mobility were conducted in whole blood in 528
              and 492 twins, respectively. Subsequently, targeted candidate
              gene analysis at 28 genomic regions was carried out testing for
              phenotype-methylation associations in 41 (tooth mobility) and 43
              (gingival bleeding) buccal, and 501 (tooth mobility) and 556
              (gingival bleeding) adipose DNA samples. RESULTS: Epigenome-wide
              analyses in blood identified one CpG-site (cg21245277 in ZNF804A)
              associated with gingival bleeding (FDR = 0.03, nominal p value =
              7.17e-8) and 58 sites associated with tooth mobility (FDR < 0.05)
              with the top signals in IQCE and XKR6. Epigenetic variation at 28
              candidate regions (247 CpG-sites) for chronic periodontitis
              showed an enrichment for association with periodontal traits, and
              signals in eight genes (VDR, IL6ST, TMCO6, IL1RN, CD44, IL1B,
              WHAMM, and CXCL1) were significant in both traits. The
              methylation-phenotype association signals validated in buccal
              samples, and a subset (25\%) also validated in adipose tissue.
              CONCLUSIONS: Epigenome-wide analyses in adult female twins
              identified specific DNA methylation changes linked to
              self-reported periodontal disease. Future work will explore the
              environmental basis and functional impact of these results to
              infer potential for strategic personalized treatments and
              prevention of chronic periodontitis.",
  journal  = "Clin. Epigenetics",
  volume   =  11,
  number   =  1,
  pages    = "27",
  month    =  feb,
  year     =  2019,
  keywords = "DNA methylation; Epigenetics; Epigenome-wide association scan
              (EWAS); Gene expression; Metabolomics; Periodontitis",
  language = "en"
}

@ARTICLE{Dabin2020-iw,
  title    = "Altered {DNA} methylation profiles in blood from patients with
              sporadic {Creutzfeldt-Jakob} disease",
  author   = "Dabin, Luke C and Guntoro, Fernando and Campbell, Tracy and
              B{\'e}licard, Tony and Smith, Adam R and Smith, Rebecca G and
              Raybould, Rachel and Schott, Jonathan M and Lunnon, Katie and
              Sarkies, Peter and Collinge, John and Mead, Simon and Vir{\'e},
              Emmanuelle",
  abstract = "Prion diseases are fatal and transmissible neurodegenerative
              disorders caused by the misfolding and aggregation of prion
              protein. Although recent studies have implicated epigenetic
              variation in common neurodegenerative disorders, no study has yet
              explored their role in human prion diseases. Here we profiled
              genome-wide blood DNA methylation in the most common human prion
              disease, sporadic Creutzfeldt-Jakob disease (sCJD). Our
              case-control study (n = 219), when accounting for differences in
              cell type composition between individuals, identified 38 probes
              at genome-wide significance (p < 1.24 $\times$ 10-7). Nine of
              these sites were taken forward in a replication study, performed
              in an independent case-control (n = 186) cohort using
              pyrosequencing. Sites in or close to FKBP5, AIM2 (2 probes),
              UHRF1, KCNAB2 successfully replicated. The blood-based DNA
              methylation signal was tissue- and disease-specific, in that the
              replicated probe signals were unchanged in case-control studies
              using sCJD frontal-cortex (n = 84), blood samples from patients
              with Alzheimer's disease, and from inherited and acquired prion
              diseases. Machine learning algorithms using blood DNA methylation
              array profiles accurately distinguished sCJD patients and
              controls. Finally, we identified sites whose methylation levels
              associated with prolonged survival in sCJD patients. Altogether,
              this study has identified a peripheral DNA methylation signature
              of sCJD with a variety of potential biomarker applications.",
  journal  = "Acta Neuropathol.",
  volume   =  140,
  number   =  6,
  pages    = "863--879",
  month    =  dec,
  year     =  2020,
  keywords = "Blood; DNA methylation; Disease duration; Neurodegeneration;
              Prion disease; sCJD",
  language = "en"
}

@MISC{Lu2014-dz,
  title   = "{REST} and stress resistance in ageing and Alzheimer's disease",
  author  = "Lu, Tao and Aron, Liviu and Zullo, Joseph and Pan, Ying and Kim,
             Haeyoung and Chen, Yiwen and Yang, Tun-Hsiang and Kim, Hyun-Min
             and Drake, Derek and Shirley Liu, X and Bennett, David A and
             Colai{\'a}covo, Monica P and Yankner, Bruce A",
  journal = "Nature",
  volume  =  507,
  number  =  7493,
  pages   = "448--454",
  year    =  2014
}

@ARTICLE{Mohamed2020-he,
  title    = "Implication of {JAK1/STAT3/SOCS3} Pathway in Aging of Cerebellum
              of Male Rat: Histological and Molecular study",
  author   = "Mohamed, Enas Ahmed and Sayed, Walaa Mohamed",
  abstract = "Aging causes morphological and functional changes in the
              cerebellum. This work aimed to demonstrate the implication of
              JAK1/STAT3/SOCS3 on aging-induced changes of rat cerebellum.
              Thirty male rats were divided into: adult (12 months), early
              senile (24 months) and late senile (32 months) groups.
              Immunohistochemical reaction of the cerebellum to GFAP and
              caspase-3 was assessed and the expression of JAK1, STAT3, SOCS3
              proteins was also evaluated. TNF$\alpha$ as well as the
              activities of malondialdehyde (MDA) and reduced glutathione (GSH)
              in cerebellar tissue were also measured. The cerebellum of late
              senile rats revealed more degenerative changes than early senile
              rats in the form of increase in GFAP and caspase-3
              immunoreaction. Additionally, there was decrease in JAK1and STAT3
              expression in early and late senile rats and increase in SOCS3
              when compare early and late senile groups with adult one.
              Enhancement of TNF$\alpha$ was noticed with aging as well as
              significant decrease in GSH and increase in MDA in early senile
              group. Moreover, late senile group revealed significant decrease
              in GSH and increase in MDA. It could be concluded that aging
              resulting in variable changes of the cerebellum as detected by
              morphological changes, immunohistochemical reactions of caspase-3
              and GFAP and expression of JAK1/STAT3/SOCS3 proteins.
              Additionally, inflammatory marker TNF$\alpha$ and the activity of
              oxidative/antioxidative stress markers; malondialdehyde (MDA) and
              reduced glutathione (GSH) were also affected with aging.",
  journal  = "Sci. Rep.",
  volume   =  10,
  number   =  1,
  pages    = "8840",
  month    =  jun,
  year     =  2020,
  language = "en"
}

@MISC{Zannas2019-me,
  title   = "Epigenetic upregulation of {FKBP5} by aging and stress contributes
             to {NF-$\kappa$B--driven} inflammation and cardiovascular risk",
  author  = "Zannas, Anthony S and Jia, Meiwen and Hafner, Kathrin and Baumert,
             Jens and Wiechmann, Tobias and Pape, Julius C and Arloth, Janine
             and K{\"o}del, Maik and Martinelli, Silvia and Roitman, Maria and
             R{\"o}h, Simone and Haehle, Andreas and Emeny, Rebecca T and
             Iurato, Stella and Carrillo-Roa, Tania and Lahti, Jari and
             R{\"a}ikk{\"o}nen, Katri and Eriksson, Johan G and Drake, Amanda J
             and Waldenberger, Melanie and Wahl, Simone and Kunze, Sonja and
             Lucae, Susanne and Bradley, Bekh and Gieger, Christian and Hausch,
             Felix and Smith, Alicia K and Ressler, Kerry J and
             M{\"u}ller-Myhsok, Bertram and Ladwig, Karl-Heinz and Rein, Theo
             and Gassen, Nils C and Binder, Elisabeth B",
  journal = "Proceedings of the National Academy of Sciences",
  volume  =  116,
  number  =  23,
  pages   = "11370--11379",
  year    =  2019
}

@ARTICLE{Armstrong2017-vg,
  title    = "Aging, exceptional longevity and comparisons of the Hannum and
              Horvath epigenetic clocks",
  author   = "Armstrong, Nicola J and Mather, Karen A and Thalamuthu, Anbupalam
              and Wright, Margaret J and Trollor, Julian N and Ames, David and
              Brodaty, Henry and Schofield, Peter R and Sachdev, Perminder S
              and Kwok, John B",
  abstract = "AIM: To examine the relationships between two epigenetic clocks,
              aging and exceptional longevity. MATERIALS \& METHODS:
              Participants were from three adult cohorts with blood DNA
              methylation data (Illumina 450 K, n = 275, 34-103 years).
              Epigenetic age (DNAmage) and age acceleration measures were
              calculated using the Hannum and Horvath epigenetic clocks.
              RESULTS: Across all cohorts, DNAmage was correlated with
              chronological age. In the long-lived cohort (Sydney Centenarian
              Study; 95+, n = 23), DNAmage was lower than chronological age for
              both clocks. Mean Sydney Centenarian Study Hannum age
              acceleration was negative, while the converse was observed for
              the Horvath model. CONCLUSION: Long-lived individuals have a
              young epigenetic age compared with their chronological age.",
  journal  = "Epigenomics",
  volume   =  9,
  number   =  5,
  pages    = "689--700",
  month    =  may,
  year     =  2017,
  keywords = "DNAmage; acceleration; age; aging; centenarians; epigenetic
              clock; longevity",
  language = "en"
}

@ARTICLE{Dugue2018-ad,
  title    = "{DNA} methylation-based biological aging and cancer risk and
              survival: Pooled analysis of seven prospective studies",
  author   = "Dugu{\'e}, Pierre-Antoine and Bassett, Julie K and Joo, Jihoon E
              and Jung, Chol-Hee and Ming Wong, Ee and Moreno-Betancur,
              Margarita and Schmidt, Daniel and Makalic, Enes and Li, Shuai and
              Severi, Gianluca and Hodge, Allison M and Buchanan, Daniel D and
              English, Dallas R and Hopper, John L and Southey, Melissa C and
              Giles, Graham G and Milne, Roger L",
  abstract = "The association between aging and cancer is complex. Recent
              studies have developed measures of biological aging based on DNA
              methylation and called them ``age acceleration.'' We aimed to
              assess the associations of age acceleration with risk of and
              survival from seven common cancers. Seven case-control studies of
              DNA methylation and colorectal, gastric, kidney, lung, prostate
              and urothelial cancer and B-cell lymphoma nested in the Melbourne
              Collaborative Cohort Study were conducted. Cancer cases, vital
              status and cause of death were ascertained through linkage with
              cancer and death registries. Conditional logistic regression and
              Cox models were used to estimate odds ratios (OR) and hazard
              ratios (HR) and 95\% confidence intervals (CI) for associations
              of five age acceleration measures derived from the Human
              Methylation 450 K Beadchip assay with cancer risk (N = 3,216
              cases) and survival (N = 1,726 deaths), respectively. Epigenetic
              aging was associated with increased cancer risk, ranging from 4\%
              to 9\% per five-year age acceleration for the 5 measures
              considered. Heterogeneity by study was observed, with stronger
              associations for risk of kidney cancer and B-cell lymphoma. An
              associated increased risk of death following cancer diagnosis
              ranged from 2\% to 6\% per five-year age acceleration, with no
              evidence of heterogeneity by cancer site. Cancer risk and
              mortality were increased by 15-30\% for the fourth versus first
              quartile of age acceleration. DNA methylation-based measures of
              biological aging are associated with increased cancer risk and
              shorter cancer survival, independently of major health risk
              factors.",
  journal  = "Int. J. Cancer",
  volume   =  142,
  number   =  8,
  pages    = "1611--1619",
  month    =  apr,
  year     =  2018,
  keywords = "DNA methylation; age acceleration; aging; biological age; blood;
              epigenetic aging; epigenetic clock; lymphoma; prospective study;
              survival",
  language = "en"
}

@ARTICLE{Snir2019-ii,
  title    = "Human epigenetic ageing is logarithmic with time across the
              entire lifespan",
  author   = "Snir, Sagi and Farrell, Colin and Pellegrini, Matteo",
  abstract = "Epigenetic changes during ageing have been characterized by
              multiple epigenetic clocks that allow the prediction of
              chronological age based on methylation status. Despite their
              accuracy and utility, epigenetic age biomarkers leave many
              questions about epigenetic ageing unanswered. Specifically, they
              do not permit the unbiased characterization of non-linear
              epigenetic ageing trends across entire life spans, a critical
              question underlying this field of research. Here we provide an
              integrated framework to address this question. Our model,
              inspired from evolutionary models, is able to account for
              acceleration/deceleration in epigenetic changes by fitting an
              individual's model age, the epigenetic age, which is related to
              chronological age in a non-linear fashion. Application of this
              model to DNA methylation data measured across broad age ranges,
              from before birth to old age, and from two tissue types, suggests
              a universal logarithmic trend characterizes epigenetic ageing
              across entire lifespans.",
  journal  = "Epigenetics",
  volume   =  14,
  number   =  9,
  pages    = "912--926",
  month    =  sep,
  year     =  2019,
  keywords = "Aging; DNA methylation",
  language = "en"
}

@ARTICLE{Farrell2020-bn,
  title    = "The Epigenetic Pacemaker: modeling epigenetic states under an
              evolutionary framework",
  author   = "Farrell, Colin and Snir, Sagi and Pellegrini, Matteo",
  abstract = "SUMMARY: Epigenetic rates of change, much as evolutionary
              mutation rate along a lineage, vary during lifetime. Accurate
              estimation of the epigenetic state has vast medical and
              biological implications. To account for these non-linear
              epigenetic changes with age, we recently developed a formalism
              inspired by the Pacemaker model of evolution that accounts for
              varying rates of mutations with time. Here, we present a python
              implementation of the Epigenetic Pacemaker (EPM), a conditional
              expectation maximization algorithm that estimates epigenetic
              landscapes and the state of individuals and may be used to study
              non-linear epigenetic aging. AVAILABILITY AND IMPLEMENTATION: The
              EPM is available at https://pypi.org/project/EpigeneticPacemaker/
              under the MIT license. The EPM is compatible with python version
              3.6 and above.",
  journal  = "Bioinformatics",
  volume   =  36,
  number   =  17,
  pages    = "4662--4663",
  month    =  nov,
  year     =  2020,
  language = "en"
}

@ARTICLE{Han2020-zj,
  title    = "New targeted approaches for epigenetic age predictions",
  author   = "Han, Yang and Franzen, Julia and Stiehl, Thomas and Gobs, Michael
              and Kuo, Chao-Chung and Nikoli{\'c}, Milo{\v s} and Hapala, Jan
              and Koop, Barbara Elisabeth and Strathmann, Klaus and Ritz-Timme,
              Stefanie and Wagner, Wolfgang",
  abstract = "BACKGROUND: Age-associated DNA methylation changes provide a
              promising biomarker for the aging process. While genome-wide DNA
              methylation profiles enable robust age-predictors by integration
              of many age-associated CG dinucleotides (CpGs), there are various
              alternative approaches for targeted measurements at specific CpGs
              that better support standardized and cost-effective
              high-throughput analysis. RESULTS: In this study, we utilized
              4647 Illumina BeadChip profiles of blood to select CpG sites that
              facilitate reliable age-predictions based on pyrosequencing. We
              demonstrate that the precision of DNA methylation measurements
              can be further increased with droplet digital PCR (ddPCR). In
              comparison, bisulfite barcoded amplicon sequencing (BBA-seq) gave
              slightly lower correlation between chronological age and DNA
              methylation at individual CpGs, while the age-predictions were
              overall relatively accurate. Furthermore, BBA-seq data revealed
              that the correlation of methylation levels with age at
              neighboring CpG sites follows a bell-shaped curve, often
              associated with a CTCF binding site. We demonstrate that within
              individual BBA-seq reads the DNA methylation at neighboring CpGs
              is not coherently modified, but reveals a stochastic pattern.
              Based on this, we have developed a new approach for epigenetic
              age predictions based on the binary sequel of methylated and
              non-methylated sites in individual reads, which reflects
              heterogeneity in epigenetic aging within a sample. CONCLUSION:
              Targeted DNA methylation analysis at few age-associated CpGs by
              pyrosequencing, BBA-seq, and particularly ddPCR enables high
              precision of epigenetic age-predictions. Furthermore, we
              demonstrate that the stochastic evolution of age-associated DNA
              methylation patterns in BBA-seq data enables epigenetic clocks
              for individual DNA strands.",
  journal  = "BMC Biol.",
  volume   =  18,
  number   =  1,
  pages    = "71",
  month    =  jun,
  year     =  2020,
  keywords = "Aging; Amplicon sequencing; Blood; Buccal swabs; CTCF; DNA
              methylation; Droplet digital PCR; Epigenetic; Human",
  language = "en"
}

@ARTICLE{Belsky2020-ha,
  title    = "Quantification of the pace of biological aging in humans through
              a blood test, the {DunedinPoAm} {DNA} methylation algorithm",
  author   = "Belsky, Daniel W and Caspi, Avshalom and Arseneault, Louise and
              Baccarelli, Andrea and Corcoran, David L and Gao, Xu and Hannon,
              Eiliss and Harrington, Hona Lee and Rasmussen, Line Jh and Houts,
              Renate and Huffman, Kim and Kraus, William E and Kwon, Dayoon and
              Mill, Jonathan and Pieper, Carl F and Prinz, Joseph A and
              Poulton, Richie and Schwartz, Joel and Sugden, Karen and Vokonas,
              Pantel and Williams, Benjamin S and Moffitt, Terrie E",
  abstract = "Biological aging is the gradual, progressive decline in system
              integrity that occurs with advancing chronological age, causing
              morbidity and disability. Measurements of the pace of aging are
              needed as surrogate endpoints in trials of therapies designed to
              prevent disease by slowing biological aging. We report a
              blood-DNA-methylation measure that is sensitive to variation in
              pace of biological aging among individuals born the same year. We
              first modeled change-over-time in 18 biomarkers tracking
              organ-system integrity across 12 years of follow-up in n = 954
              members of the Dunedin Study born in 1972-1973. Rates of change
              in each biomarker over ages 26-38 years were composited to form a
              measure of aging-related decline, termed Pace-of-Aging.
              Elastic-net regression was used to develop a DNA-methylation
              predictor of Pace-of-Aging, called DunedinPoAm for
              Dunedin(P)ace(o)f(A)ging(m)ethylation. Validation analysis in
              cohort studies and the CALERIE trial provide proof-of-principle
              for DunedinPoAm as a single-time-point measure of a person's pace
              of biological aging.",
  journal  = "Elife",
  volume   =  9,
  month    =  may,
  year     =  2020,
  keywords = "DNA methylation; aging; biological aging; epidemiology;
              epigenetic; global health; human; life-course",
  language = "en"
}

@ARTICLE{Varoquaux2009-al,
  title   = "Joblib: running python function as pipeline jobs",
  author  = "Varoquaux, Ga{\"e}l and Grisel, O",
  journal = "packages. python. org/joblib",
  year    =  2009
}

@ARTICLE{Levine2018-en,
  title    = "An epigenetic biomarker of aging for lifespan and healthspan",
  author   = "Levine, Morgan E and Lu, Ake T and Quach, Austin and Chen, Brian
              H and Assimes, Themistocles L and Bandinelli, Stefania and Hou,
              Lifang and Baccarelli, Andrea A and Stewart, James D and Li, Yun
              and Whitsel, Eric A and Wilson, James G and Reiner, Alex P and
              Aviv, Abraham and Lohman, Kurt and Liu, Yongmei and Ferrucci,
              Luigi and Horvath, Steve",
  abstract = "Identifying reliable biomarkers of aging is a major goal in
              geroscience. While the first generation of epigenetic biomarkers
              of aging were developed using chronological age as a surrogate
              for biological age, we hypothesized that incorporation of
              composite clinical measures of phenotypic age that capture
              differences in lifespan and healthspan may identify novel CpGs
              and facilitate the development of a more powerful epigenetic
              biomarker of aging. Using an innovative two-step process, we
              develop a new epigenetic biomarker of aging, DNAm PhenoAge, that
              strongly outperforms previous measures in regards to predictions
              for a variety of aging outcomes, including all-cause mortality,
              cancers, healthspan, physical functioning, and Alzheimer's
              disease. While this biomarker was developed using data from whole
              blood, it correlates strongly with age in every tissue and cell
              tested. Based on an in-depth transcriptional analysis in sorted
              cells, we find that increased epigenetic, relative to
              chronological age, is associated with increased activation of
              pro-inflammatory and interferon pathways, and decreased
              activation of transcriptional/translational machinery, DNA damage
              response, and mitochondrial signatures. Overall, this single
              epigenetic biomarker of aging is able to capture risks for an
              array of diverse outcomes across multiple tissues and cells, and
              provide insight into important pathways in aging.",
  journal  = "Aging",
  volume   =  10,
  number   =  4,
  pages    = "573--591",
  month    =  apr,
  year     =  2018,
  keywords = "epigenetic clock; DNA methylation; biomarker;
              healthspan;References from .bib",
  language = "en"
}

@ARTICLE{Horvath2015-af,
  title    = "Increased epigenetic age and granulocyte counts in the blood of
              Parkinson's disease patients",
  author   = "Horvath, Steve and Ritz, Beate R",
  abstract = "It has been a long standing hypothesis that blood tissue of PD
              Parkinson's disease (PD) patients may exhibit signs of
              accelerated aging. Here we use DNA methylation based biomarkers
              of aging (``epigenetic clock'') to assess the aging rate of blood
              in two ethnically distinct case-control data sets. Using n=508
              Caucasian and n=84 Hispanic blood samples, we assess a) the
              intrinsic epigenetic age acceleration of blood (IEAA), which is
              independent of blood cell counts, and b) the extrinsic epigenetic
              age acceleration rate of blood (EEAA) which is associated with
              age dependent changes in blood cell counts. Blood of PD subjects
              exhibits increased age acceleration according to both IEAA
              (p=0.019) and EEAA (p=6.1 x 10(-3)). We find striking differences
              in imputed blood cell counts between PD cases and controls.
              Compared to control subjects, PD subjects contains more
              granulocytes (p=1.0 x 10(-9) in Caucasians, p=0.00066 in
              Hispanics) but fewer T helper cells (p=1.4 x 10(-6) in
              Caucasians, p=0.0024 in Hispanics) and fewer B cells (p=1.6 x
              10(-5) in Caucasians, p=4.5 x 10(-5) in Hispanics). Overall, this
              study shows that the epigenetic age of the immune system is
              significantly increased in PD patients and that granulocytes play
              a significant role.",
  journal  = "Aging",
  volume   =  7,
  number   =  12,
  pages    = "1130--1142",
  month    =  dec,
  year     =  2015,
  keywords = "DNA methylation; Parkinson's disease; epigenetic clock;
              epigenetics; granulocyte; neutrophil",
  language = "en"
}

@ARTICLE{Tan2014-sg,
  title    = "Epigenetic signature of birth weight discordance in adult twins",
  author   = "Tan, Qihua and Frost, Morten and Heijmans, Bastiaan T and von
              Bornemann Hjelmborg, Jacob and Tobi, Elmar W and Christensen,
              Kaare and Christiansen, Lene",
  abstract = "BACKGROUND: A low birth weight has been extensively related to
              poor adult health outcomes. Birth weight can be seen as a proxy
              for environmental conditions during prenatal development.
              Identical twin pairs discordant for birth weight provide an
              extraordinary model for investigating the association between
              birth weight and adult life health while controlling for not only
              genetics but also postnatal rearing environment. We performed an
              epigenome-wide profiling on blood samples from 150 pairs of adult
              monozygotic twins discordant for birth weight to look for
              molecular evidence of epigenetic signatures in association with
              birth weight discordance. RESULTS: Our association analysis
              revealed no CpG site with genome-wide statistical significance
              (FDR < 0.05) for either qualitative (larger or smaller) or
              quantitative discordance in birth weight. Even with selected
              samples of extremely birth weight discordant twin pairs, no
              significant site was found except for 3 CpGs that displayed
              age-dependent intra-pair differential methylation with FDRs 0.014
              (cg26856578, p = 3.42e-08), 0.0256 (cg15122603, p = 1.25e-07) and
              0.0258 (cg16636641, p = 2.05e-07). Among the three sites,
              intra-pair differential methylation increased with age for
              cg26856578 but decreased with age for cg15122603 and cg16636641.
              There was no genome-wide statistical significance for
              sex-dependent effects on intra-pair differential methylation in
              either the whole samples or the extremely discordant twins.
              CONCLUSIONS: Genome-wide DNA methylation profiling did not reveal
              epigenetic signatures of birth weight discordance although some
              sites displayed age-dependent intra-pair differential methylation
              in the extremely discordant twin pairs.",
  journal  = "BMC Genomics",
  volume   =  15,
  pages    = "1062",
  month    =  dec,
  year     =  2014,
  language = "en"
}

@ARTICLE{Arloth2020-lo,
  title    = "{DeepWAS}: Multivariate genotype-phenotype associations by
              directly integrating regulatory information using deep learning",
  author   = "Arloth, Janine and Eraslan, G{\"o}kcen and Andlauer, Till F M and
              Martins, Jade and Iurato, Stella and K{\"u}hnel, Brigitte and
              Waldenberger, Melanie and Frank, Josef and Gold, Ralf and Hemmer,
              Bernhard and Luessi, Felix and Nischwitz, Sandra and Paul,
              Friedemann and Wiendl, Heinz and Gieger, Christian and
              Heilmann-Heimbach, Stefanie and Kacprowski, Tim and Laudes,
              Matthias and Meitinger, Thomas and Peters, Annette and Rawal,
              Rajesh and Strauch, Konstantin and Lucae, Susanne and
              M{\"u}ller-Myhsok, Bertram and Rietschel, Marcella and Theis,
              Fabian J and Binder, Elisabeth B and Mueller, Nikola S",
  abstract = "Genome-wide association studies (GWAS) identify genetic variants
              associated with traits or diseases. GWAS never directly link
              variants to regulatory mechanisms. Instead, the functional
              annotation of variants is typically inferred by post hoc
              analyses. A specific class of deep learning-based methods allows
              for the prediction of regulatory effects per variant on several
              cell type-specific chromatin features. We here describe
              ``DeepWAS'', a new approach that integrates these regulatory
              effect predictions of single variants into a multivariate GWAS
              setting. Thereby, single variants associated with a trait or
              disease are directly coupled to their impact on a chromatin
              feature in a cell type. Up to 61 regulatory SNPs, called dSNPs,
              were associated with multiple sclerosis (MS, 4,888 cases and
              10,395 controls), major depressive disorder (MDD, 1,475 cases and
              2,144 controls), and height (5,974 individuals). These variants
              were mainly non-coding and reached at least nominal significance
              in classical GWAS. The prediction accuracy was higher for DeepWAS
              than for classical GWAS models for 91\% of the genome-wide
              significant, MS-specific dSNPs. DSNPs were enriched in public or
              cohort-matched expression and methylation quantitative trait loci
              and we demonstrated the potential of DeepWAS to generate testable
              functional hypotheses based on genotype data alone. DeepWAS is
              available at https://github.com/cellmapslab/DeepWAS.",
  journal  = "PLoS Comput. Biol.",
  volume   =  16,
  number   =  2,
  pages    = "e1007616",
  month    =  feb,
  year     =  2020,
  language = "en"
}

@ARTICLE{Zheng2019-vm,
  title    = "Cistrome Data Browser: expanded datasets and new tools for gene
              regulatory analysis",
  author   = "Zheng, Rongbin and Wan, Changxin and Mei, Shenglin and Qin, Qian
              and Wu, Qiu and Sun, Hanfei and Chen, Chen-Hao and Brown, Myles
              and Zhang, Xiaoyan and Meyer, Clifford A and Liu, X Shirley",
  abstract = "The Cistrome Data Browser (DB) is a resource of human and mouse
              cis-regulatory information derived from ChIP-seq, DNase-seq and
              ATAC-seq chromatin profiling assays, which map the genome-wide
              locations of transcription factor binding sites, histone
              post-translational modifications and regions of chromatin
              accessible to endonuclease activity. Currently, the Cistrome DB
              contains approximately 47,000 human and mouse samples with about
              24,000 newly collected datasets compared to the previous release
              two years ago. Furthermore, the Cistrome DB has a new Toolkit
              module with several features that allow users to better utilize
              the large-scale ChIP-seq, DNase-seq, and ATAC-seq data. First,
              users can query the factors which are likely to regulate a
              specific gene of interest. Second, the Cistrome DB Toolkit
              facilitates searches for factor binding, histone modifications,
              and chromatin accessibility in any given genomic interval shorter
              than 2Mb. Third, the Toolkit can determine the most similar
              ChIP-seq, DNase-seq, and ATAC-seq samples in terms of genomic
              interval overlaps with user-provided genomic interval sets. The
              Cistrome DB is a user-friendly, up-to-date, and well maintained
              resource, and the new tools will greatly benefit the biomedical
              research community. The database is freely available at
              http://cistrome.org/db, and the Toolkit is at
              http://dbtoolkit.cistrome.org.",
  journal  = "Nucleic Acids Res.",
  volume   =  47,
  number   = "D1",
  pages    = "D729--D735",
  month    =  jan,
  year     =  2019,
  language = "en"
}

@ARTICLE{Mei2017-yq,
  title    = "Cistrome Data Browser: a data portal for {ChIP-Seq} and chromatin
              accessibility data in human and mouse",
  author   = "Mei, Shenglin and Qin, Qian and Wu, Qiu and Sun, Hanfei and
              Zheng, Rongbin and Zang, Chongzhi and Zhu, Muyuan and Wu, Jiaxin
              and Shi, Xiaohui and Taing, Len and Liu, Tao and Brown, Myles and
              Meyer, Clifford A and Liu, X Shirley",
  abstract = "Chromatin immunoprecipitation, DNase I hypersensitivity and
              transposase-accessibility assays combined with high-throughput
              sequencing enable the genome-wide study of chromatin dynamics,
              transcription factor binding and gene regulation. Although
              rapidly accumulating publicly available ChIP-seq, DNase-seq and
              ATAC-seq data are a valuable resource for the systematic
              investigation of gene regulation processes, a lack of
              standardized curation, quality control and analysis procedures
              have hindered extensive reuse of these data. To overcome this
              challenge, we built the Cistrome database, a collection of
              ChIP-seq and chromatin accessibility data (DNase-seq and
              ATAC-seq) published before January 1, 2016, including 13 366
              human and 9953 mouse samples. All the data have been carefully
              curated and processed with a streamlined analysis pipeline and
              evaluated with comprehensive quality control metrics. We have
              also created a user-friendly web server for data query,
              exploration and visualization. The resulting Cistrome DB
              (Cistrome Data Browser), available online at
              http://cistrome.org/db, is expected to become a valuable resource
              for transcriptional and epigenetic regulation studies.",
  journal  = "Nucleic Acids Res.",
  volume   =  45,
  number   = "D1",
  pages    = "D658--D662",
  month    =  jan,
  year     =  2017,
  language = "en"
}


@ARTICLE{Guerzoni2006-ii,
  title    = "Inducible activation of {CEBPB}, a gene negatively regulated by
              {BCR/ABL}, inhibits proliferation and promotes differentiation of
              {BCR/ABL-expressing} cells",
  author   = "Guerzoni, Clara and Bardini, Michela and Mariani, Samanta A and
              Ferrari-Amorotti, Giovanna and Neviani, Paolo and Panno, Maria
              Luisa and Zhang, Ying and Martinez, Robert and Perrotti, Danilo
              and Calabretta, Bruno",
  abstract = "Translational regulation by oncogenic proteins may be a rapid and
              efficient mechanism to modulate gene expression. We report here
              the identification of the CEBPB gene as a target of translational
              regulation in myeloid precursor cells transformed by the BCR/ABL
              oncogene. Expression of CEBPB was repressed in 32D-BCR/ABL cells
              and reinduced by imatinib (STI571) via a mechanism that appears
              to depend on expression of the CUG-repeat RNA-binding protein
              CUGBP1 and the integrity of the CUG-rich intercistronic region of
              c/ebpbeta mRNA. Constitutive expression or conditional activation
              of wild-type CEBPB induced differentiation and inhibited
              proliferation of 32D-BCR/ABL cells in vitro and in mice, but a
              DNA binding-deficient CEBPB mutant had no effect. The
              proliferation-inhibitory effect of CEBPB was, in part, mediated
              by the CEBPB-induced GADD45A gene. Because expression of CEBPB
              (and CEBPA) is low in the blast crisis (BC) stage of chronic
              myelogenous leukemia (CML) and is inversely correlated with
              BCR/ABL tyrosine kinase levels, these findings point to the
              therapeutic potential of restoring C/EBP activity in CML-BC and,
              perhaps, other types of acute leukemia.",
  journal  = "Blood",
  volume   =  107,
  number   =  10,
  pages    = "4080--4089",
  month    =  may,
  year     =  2006,
  language = "en"
}

@ARTICLE{Da_Costa-Luis2019-lr,
  title    = "tqdm: A Fast, Extensible Progress Meter for Python and {CLI}",
  author   = "da Costa-Luis, Casper O",
  abstract = "Software archive",
  journal  = "JOSS",
  volume   =  4,
  number   =  37,
  pages    = "1277",
  month    =  may,
  year     =  2019
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Aryee2014-ky,
  title    = "Minfi: a flexible and comprehensive Bioconductor package for the
              analysis of Infinium {DNA} methylation microarrays",
  author   = "Aryee, Martin J and Jaffe, Andrew E and Corrada-Bravo, Hector and
              Ladd-Acosta, Christine and Feinberg, Andrew P and Hansen, Kasper
              D and Irizarry, Rafael A",
  abstract = "MOTIVATION: The recently released Infinium HumanMethylation450
              array (the '450k' array) provides a high-throughput assay to
              quantify DNA methylation (DNAm) at 450 000 loci across a range
              of genomic features. Although less comprehensive than
              high-throughput sequencing-based techniques, this product is more
              cost-effective and promises to be the most widely used DNAm
              high-throughput measurement technology over the next several
              years. RESULTS: Here we describe a suite of computational tools
              that incorporate state-of-the-art statistical techniques for the
              analysis of DNAm data. The software is structured to easily adapt
              to future versions of the technology. We include methods for
              preprocessing, quality assessment and detection of differentially
              methylated regions from the kilobase to the megabase scale. We
              show how our software provides a powerful and flexible
              development platform for future methods. We also illustrate how
              our methods empower the technology to make discoveries previously
              thought to be possible only with sequencing-based methods.
              AVAILABILITY AND IMPLEMENTATION:
              http://bioconductor.org/packages/release/bioc/html/minfi.html.
              CONTACT: khansen@jhsph.edu; rafa@jimmy.harvard.edu SUPPLEMENTARY
              INFORMATION: Supplementary data are available at Bioinformatics
              online.",
  journal  = "Bioinformatics",
  volume   =  30,
  number   =  10,
  pages    = "1363--1369",
  month    =  may,
  year     =  2014,
  language = "en"
}

@ARTICLE{Virtanen2020-mm,
  title    = "{SciPy} 1.0: fundamental algorithms for scientific computing in
              Python",
  author   = "Virtanen, Pauli and Gommers, Ralf and Oliphant, Travis E and
              Haberland, Matt and Reddy, Tyler and Cournapeau, David and
              Burovski, Evgeni and Peterson, Pearu and Weckesser, Warren and
              Bright, Jonathan and van der Walt, St{\'e}fan J and Brett,
              Matthew and Wilson, Joshua and Millman, K Jarrod and Mayorov,
              Nikolay and Nelson, Andrew R J and Jones, Eric and Kern, Robert
              and Larson, Eric and Carey, C J and Polat, {\.I}lhan and Feng, Yu
              and Moore, Eric W and VanderPlas, Jake and Laxalde, Denis and
              Perktold, Josef and Cimrman, Robert and Henriksen, Ian and
              Quintero, E A and Harris, Charles R and Archibald, Anne M and
              Ribeiro, Ant{\^o}nio H and Pedregosa, Fabian and van Mulbregt,
              Paul and Vijaykumar, Aditya and Bardelli, Alessandro Pietro and
              Rothberg, Alex and Hilboll, Andreas and Kloeckner, Andreas and
              Scopatz, Anthony and Lee, Antony and Rokem, Ariel and Woods, C
              Nathan and Fulton, Chad and Masson, Charles and
              H{\"a}ggstr{\"o}m, Christian and Fitzgerald, Clark and Nicholson,
              David A and Hagen, David R and Pasechnik, Dmitrii V and Olivetti,
              Emanuele and Martin, Eric and Wieser, Eric and Silva, Fabrice and
              Lenders, Felix and Wilhelm, Florian and Young, G and Price, Gavin
              A and Ingold, Gert-Ludwig and Allen, Gregory E and Lee, Gregory R
              and Audren, Herv{\'e} and Probst, Irvin and Dietrich, J{\"o}rg P
              and Silterra, Jacob and Webber, James T and Slavi{\v c}, Janko
              and Nothman, Joel and Buchner, Johannes and Kulick, Johannes and
              Sch{\"o}nberger, Johannes L and de Miranda Cardoso, Jos{\'e}
              Vin{\'\i}cius and Reimer, Joscha and Harrington, Joseph and
              Rodr{\'\i}guez, Juan Luis Cano and Nunez-Iglesias, Juan and
              Kuczynski, Justin and Tritz, Kevin and Thoma, Martin and
              Newville, Matthew and K{\"u}mmerer, Matthias and Bolingbroke,
              Maximilian and Tartre, Michael and Pak, Mikhail and Smith,
              Nathaniel J and Nowaczyk, Nikolai and Shebanov, Nikolay and
              Pavlyk, Oleksandr and Brodtkorb, Per A and Lee, Perry and
              McGibbon, Robert T and Feldbauer, Roman and Lewis, Sam and
              Tygier, Sam and Sievert, Scott and Vigna, Sebastiano and
              Peterson, Stefan and More, Surhud and Pudlik, Tadeusz and Oshima,
              Takuya and Pingel, Thomas J and Robitaille, Thomas P and Spura,
              Thomas and Jones, Thouis R and Cera, Tim and Leslie, Tim and
              Zito, Tiziano and Krauss, Tom and Upadhyay, Utkarsh and
              Halchenko, Yaroslav O and V{\'a}zquez-Baeza, Yoshiki and {SciPy
              1.0 Contributors}",
  abstract = "SciPy is an open-source scientific computing library for the
              Python programming language. Since its initial release in 2001,
              SciPy has become a de facto standard for leveraging scientific
              algorithms in Python, with over 600 unique code contributors,
              thousands of dependent packages, over 100,000 dependent
              repositories and millions of downloads per year. In this work, we
              provide an overview of the capabilities and development practices
              of SciPy 1.0 and highlight some recent technical developments.",
  journal  = "Nat. Methods",
  month    =  feb,
  year     =  2020,
  keywords = "References from .bib"
}

@ARTICLE{Marabita2013-cj,
  title    = "An evaluation of analysis pipelines for {DNA} methylation
              profiling using the Illumina {HumanMethylation450} {BeadChip}
              platform",
  author   = "Marabita, Francesco and Almgren, Malin and Lindholm, Mal{\'e}ne E
              and Ruhrmann, Sabrina and Fagerstr{\"o}m-Billai, Fredrik and
              Jagodic, Maja and Sundberg, Carl J and Ekstr{\"o}m, Tomas J and
              Teschendorff, Andrew E and Tegn{\'e}r, Jesper and Gomez-Cabrero,
              David",
  abstract = "The proper identification of differentially methylated CpGs is
              central in most epigenetic studies. The Illumina
              HumanMethylation450 BeadChip is widely used to quantify DNA
              methylation; nevertheless, the design of an appropriate analysis
              pipeline faces severe challenges due to the convolution of
              biological and technical variability and the presence of a signal
              bias between Infinium I and II probe design types. Despite recent
              attempts to investigate how to analyze DNA methylation data with
              such an array design, it has not been possible to perform a
              comprehensive comparison between different bioinformatics
              pipelines due to the lack of appropriate data sets having both
              large sample size and sufficient number of technical replicates.
              Here we perform such a comparative analysis, targeting the
              problems of reducing the technical variability, eliminating the
              probe design bias and reducing the batch effect by exploiting two
              unpublished data sets, which included technical replicates and
              were profiled for DNA methylation either on peripheral blood,
              monocytes or muscle biopsies. We evaluated the performance of
              different analysis pipelines and demonstrated that: (1) it is
              critical to correct for the probe design type, since the
              amplitude of the measured methylation change depends on the
              underlying chemistry; (2) the effect of different normalization
              schemes is mixed, and the most effective method in our hands were
              quantile normalization and Beta Mixture Quantile dilation (BMIQ);
              (3) it is beneficial to correct for batch effects. In conclusion,
              our comparative analysis using a comprehensive data set suggests
              an efficient pipeline for proper identification of differentially
              methylated CpGs using the Illumina 450K arrays.",
  journal  = "Epigenetics",
  volume   =  8,
  number   =  3,
  pages    = "333--346",
  month    =  mar,
  year     =  2013,
  keywords = "DNA methylation; Illumina 450K; microarray; normalization;
              technical variability",
  language = "en"
}

@ARTICLE{Chong1995-dj,
  title    = "{REST}: a mammalian silencer protein that restricts sodium
              channel gene expression to neurons",
  author   = "Chong, J A and Tapia-Ram{\'\i}rez, J and Kim, S and Toledo-Aral,
              J J and Zheng, Y and Boutros, M C and Altshuller, Y M and
              Frohman, M A and Kraner, S D and Mandel, G",
  abstract = "Expression of the type II voltage-dependent sodium channel gene
              is restricted to neurons by a silencer element active in
              nonneuronal cells. We have cloned cDNA coding for a transcription
              factor (REST) that binds to this silencer element. Expression of
              a recombinant REST protein confers the ability to silence type II
              reporter genes in neuronal cell types lacking the native REST
              protein, whereas expression of a dominant negative form of REST
              in nonneuronal cells relieves silencing mediated by the native
              protein. REST transcripts in developing mouse embryos are
              detected ubiquitously outside of the nervous system. We propose
              that expression of the type II sodium channel gene in neurons
              reflects a default pathway that is blocked in nonneuronal cells
              by the presence of REST.",
  journal  = "Cell",
  volume   =  80,
  number   =  6,
  pages    = "949--957",
  month    =  mar,
  year     =  1995,
  language = "en"
}

@ARTICLE{Harris2020-yb,
  title    = "Array programming with {NumPy}",
  author   = "Harris, Charles R and Millman, K Jarrod and van der Walt,
              St{\'e}fan J and Gommers, Ralf and Virtanen, Pauli and
              Cournapeau, David and Wieser, Eric and Taylor, Julian and Berg,
              Sebastian and Smith, Nathaniel J and Kern, Robert and Picus,
              Matti and Hoyer, Stephan and van Kerkwijk, Marten H and Brett,
              Matthew and Haldane, Allan and Del R{\'\i}o, Jaime Fern{\'a}ndez
              and Wiebe, Mark and Peterson, Pearu and G{\'e}rard-Marchant,
              Pierre and Sheppard, Kevin and Reddy, Tyler and Weckesser, Warren
              and Abbasi, Hameer and Gohlke, Christoph and Oliphant, Travis E",
  abstract = "Array programming provides a powerful, compact and expressive
              syntax for accessing, manipulating and operating on data in
              vectors, matrices and higher-dimensional arrays. NumPy is the
              primary array programming library for the Python language. It has
              an essential role in research analysis pipelines in fields as
              diverse as physics, chemistry, astronomy, geoscience, biology,
              psychology, materials science, engineering, finance and
              economics. For example, in astronomy, NumPy was an important part
              of the software stack used in the discovery of gravitational
              waves1 and in the first imaging of a black hole2. Here we review
              how a few fundamental array concepts lead to a simple and
              powerful programming paradigm for organizing, exploring and
              analysing scientific data. NumPy is the foundation upon which the
              scientific Python ecosystem is constructed. It is so pervasive
              that several projects, targeting audiences with specialized
              needs, have developed their own NumPy-like interfaces and array
              objects. Owing to its central position in the ecosystem, NumPy
              increasingly acts as an interoperability layer between such array
              computation libraries and, together with its application
              programming interface (API), provides a flexible framework to
              support the next decade of scientific and industrial analysis.",
  journal  = "Nature",
  volume   =  585,
  number   =  7825,
  pages    = "357--362",
  month    =  sep,
  year     =  2020,
  language = "en"
}

@ARTICLE{Houseman2012-rr,
  title    = "{DNA} methylation arrays as surrogate measures of cell mixture
              distribution",
  author   = "Houseman, Eugene Andres and Accomando, William P and Koestler,
              Devin C and Christensen, Brock C and Marsit, Carmen J and Nelson,
              Heather H and Wiencke, John K and Kelsey, Karl T",
  abstract = "BACKGROUND: There has been a long-standing need in biomedical
              research for a method that quantifies the normally mixed
              composition of leukocytes beyond what is possible by simple
              histological or flow cytometric assessments. The latter is
              restricted by the labile nature of protein epitopes, requirements
              for cell processing, and timely cell analysis. In a diverse array
              of diseases and following numerous immune-toxic exposures,
              leukocyte composition will critically inform the underlying
              immuno-biology to most chronic medical conditions. Emerging
              research demonstrates that DNA methylation is responsible for
              cellular differentiation, and when measured in whole peripheral
              blood, serves to distinguish cancer cases from controls. RESULTS:
              Here we present a method, similar to regression calibration, for
              inferring changes in the distribution of white blood cells
              between different subpopulations (e.g. cases and controls) using
              DNA methylation signatures, in combination with a previously
              obtained external validation set consisting of signatures from
              purified leukocyte samples. We validate the fundamental idea in a
              cell mixture reconstruction experiment, then demonstrate our
              method on DNA methylation data sets from several studies,
              including data from a Head and Neck Squamous Cell Carcinoma
              (HNSCC) study and an ovarian cancer study. Our method produces
              results consistent with prior biological findings, thereby
              validating the approach. CONCLUSIONS: Our method, in combination
              with an appropriate external validation set, promises new
              opportunities for large-scale immunological studies of both
              disease states and noxious exposures.",
  journal  = "BMC Bioinformatics",
  volume   =  13,
  pages    = "86",
  month    =  may,
  year     =  2012,
  keywords = "References from .bib",
  language = "en"
}

@ARTICLE{Hinrichs2006-oq,
  title    = "The {UCSC} Genome Browser Database: update 2006",
  author   = "Hinrichs, A S and Karolchik, D and Baertsch, R and Barber, G P
              and Bejerano, G and Clawson, H and Diekhans, M and Furey, T S and
              Harte, R A and Hsu, F and Hillman-Jackson, J and Kuhn, R M and
              Pedersen, J S and Pohl, A and Raney, B J and Rosenbloom, K R and
              Siepel, A and Smith, K E and Sugnet, C W and Sultan-Qurraie, A
              and Thomas, D J and Trumbower, H and Weber, R J and Weirauch, M
              and Zweig, A S and Haussler, D and Kent, W J",
  abstract = "The University of California Santa Cruz Genome Browser Database
              (GBD) contains sequence and annotation data for the genomes of
              about a dozen vertebrate species and several major model
              organisms. Genome annotations typically include assembly data,
              sequence composition, genes and gene predictions, mRNA and
              expressed sequence tag evidence, comparative genomics,
              regulation, expression and variation data. The database is
              optimized to support fast interactive performance with web tools
              that provide powerful visualization and querying capabilities for
              mining the data. The Genome Browser displays a wide variety of
              annotations at all scales from single nucleotide level up to a
              full chromosome. The Table Browser provides direct access to the
              database tables and sequence data, enabling complex queries on
              genome-wide datasets. The Proteome Browser graphically displays
              protein properties. The Gene Sorter allows filtering and
              comparison of genes by several metrics including expression data
              and several gene properties. BLAT and In Silico PCR search for
              sequences in entire genomes in seconds. These tools are highly
              integrated and provide many hyperlinks to other databases and
              websites. The GBD, browsing tools, downloadable data files and
              links to documentation and other information can be found at
              http://genome.ucsc.edu/.",
  journal  = "Nucleic Acids Res.",
  volume   =  34,
  number   = "Database issue",
  pages    = "D590--8",
  month    =  jan,
  year     =  2006,
  language = "en"
}

@ARTICLE{Sheffield2016-wg,
  title    = "{LOLA}: enrichment analysis for genomic region sets and
              regulatory elements in {R} and Bioconductor",
  author   = "Sheffield, Nathan C and Bock, Christoph",
  abstract = "UNLABELLED: Genomic datasets are often interpreted in the context
              of large-scale reference databases. One approach is to identify
              significantly overlapping gene sets, which works well for
              gene-centric data. However, many types of high-throughput data
              are based on genomic regions. Locus Overlap Analysis (LOLA)
              provides easy and automatable enrichment analysis for genomic
              region sets, thus facilitating the interpretation of functional
              genomics and epigenomics data. AVAILABILITY AND IMPLEMENTATION: R
              package available in Bioconductor and on the following website:
              http://lola.computational-epigenetics.org.",
  journal  = "Bioinformatics",
  volume   =  32,
  number   =  4,
  pages    = "587--589",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@ARTICLE{Soriano-Tarraga2016-uq,
  title    = "Epigenome-wide association study identifies {TXNIP} gene
              associated with type 2 diabetes mellitus and sustained
              hyperglycemia",
  author   = "Soriano-T{\'a}rraga, Carolina and Jim{\'e}nez-Conde, Jordi and
              Giralt-Steinhauer, Eva and Mola-Caminal, Marina and
              Vivanco-Hidalgo, Rosa M and Ois, Angel and
              Rodr{\'\i}guez-Campello, Ana and Cuadrado-Godia, Elisa and
              Sayols-Baixeras, Sergi and Elosua, Roberto and Roquer, Jaume and
              {GENESTROKE Consortium}",
  abstract = "Type 2 diabetes mellitus (DM) is an established risk factor for a
              wide range of vascular diseases, including ischemic stroke (IS).
              Glycated hemoglobin A1c (HbA1c), a marker for average blood
              glucose levels over the previous 12 weeks, is used as a measure
              of glycemic control and also as a diagnostic criterion for
              diabetes (HbA1c levels $\geq$ 6.5\%). Epigenetic mechanisms, such
              as DNA methylation, may be associated with aging processes and
              with modulation of the risk of various pathologies, such as DM.
              Specifically, DNA methylation could be one of the mechanisms
              mediating the relation between DM and environmental exposures.
              Our goal was to identify new CpG methylation sites associated
              with DM. We performed a genome-wide methylation study in
              whole-blood DNA from an IS patient cohorts. Illumina
              HumanMethylation450 BeadChip array was used to measure DNA
              methylation in CpG sites. All statistical analyses were adjusted
              for sex, age, hyperlipidemia, body mass index (BMI), smoking
              habit and cell count. Findings were replicated in two independent
              cohorts, an IS cohort and a population-based cohort, using the
              same array. In the discovery phase (N = 355), we identified a CpG
              site, cg19693031 (located in the TXNIP gene) that was associated
              with DM (P = 1.17 $\times$ 10(-12)); this CpG was replicated in
              two independent cohorts (N = 167 and N = 645). Methylation of
              TXNIP was inversely and intensely associated with HbA1c levels (P
              = 7.3 $\times$ 10(-16)), specifically related to diabetic
              patients with poor control of glucose levels. We identified an
              association between the TXNIP gene and DM through epigenetic
              mechanisms, related to sustained hyperglycemia levels (HbA1c
              $\geq$ 7\%).",
  journal  = "Hum. Mol. Genet.",
  volume   =  25,
  number   =  3,
  pages    = "609--619",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@ARTICLE{De_Lima_Camillo2022-lu,
  title     = "A pan-tissue {DNA-methylation} epigenetic clock based on deep
               learning",
  author    = "de Lima Camillo, Lucas Paulo and Lapierre, Louis R and Singh,
               Ritambhara",
  abstract  = "Several age predictors based on DNA methylation, dubbed
               epigenetic clocks, have been created in recent years, with the
               vast majority based on regularized linear regression. This study
               explores the improvement in the performance and interpretation
               of epigenetic clocks using deep learning. First, we gathered 142
               publicly available data sets from several human tissues to
               develop AltumAge, a neural network framework that is a highly
               accurate and precise age predictor. Compared to ElasticNet,
               AltumAge performs better for within-data set and cross-data set
               age prediction, being particularly more generalizable in older
               ages and new tissue types. We then used deep learning
               interpretation methods to learn which methylation sites
               contributed to the final model predictions. We observe that
               while most important CpG sites are linearly related to age, some
               highly-interacting CpG sites can influence the relevance of such
               relationships. Using chromatin annotations, we show that the CpG
               sites with the highest contribution to the model predictions
               were related to gene regulatory regions in the genome, including
               proximity to CTCF binding sites. We also found age-related KEGG
               pathways for genes containing these CpG sites. Lastly, we
               performed downstream analyses of AltumAge to explore its
               applicability and compare its age acceleration with Horvath's
               2013 model. We show that our neural network approach predicts
               higher age acceleration for tumors, for cells that exhibit
               age-related changes in vitro, such as immune and mitochondrial
               dysfunction, and for samples from patients with multiple
               sclerosis, type 2 diabetes, and HIV, among other conditions.
               Altogether, our neural network approach provides significant
               improvement and flexibility compared to current epigenetic
               clocks for both performance and model interpretability.",
  journal   = "npj Aging",
  publisher = "Nature Publishing Group",
  volume    =  8,
  number    =  1,
  pages     = "1--15",
  month     =  apr,
  year      =  2022,
  language  = "en"
}

@ARTICLE{Barrett2012-gu,
  title     = "{NCBI} {GEO}: archive for functional genomics data sets---update",
  author    = "Barrett, Tanya and Wilhite, Stephen E and Ledoux, Pierre and
               Evangelista, Carlos and Kim, Irene F and Tomashevsky, Maxim and
               Marshall, Kimberly A and Phillippy, Katherine H and Sherman,
               Patti M and Holko, Michelle and Yefanov, Andrey and Lee,
               Hyeseung and Zhang, Naigong and Robertson, Cynthia L and Serova,
               Nadezhda and Davis, Sean and Soboleva, Alexandra",
  abstract  = "Abstract. The Gene Expression Omnibus (GEO,
               http://www.ncbi.nlm.nih.gov/geo/) is an international public
               repository for high-throughput microarray and next-gene",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford Academic",
  volume    =  41,
  number    = "D1",
  pages     = "D991--D995",
  month     =  nov,
  year      =  2012,
  keywords  = "internet",
  language  = "en"
}

@MISC{ValleG2019-xi,
  title    = "{GSE128064}",
  author   = "del Valle J and Campos O and Santacana M and Matias-Guiu X and L{\'a}zaro C and
              Valle L and Brunet J and Pineda M and Capell{\'a} G, D{\'a}maso E and
              Gonz{\'a}lez-Acosta M and Vargas-Parra G and Navarro M and Balma{\~n}a J and
              Ramon y Cajal T and Tuset N and Thompson Ba and Mar{\'\i}n F and
              Fern{\'a}ndez A and G{\'o}mez C and Velasco {\`A} and Solanes A and Iglesias
              S, Urgel G and L{\'o}pez C",
  month    =  mar,
  year     =  2019,
  note     = "Title of the publication associated with this dataset:
              Comprehensive constitutional genetic and epigenetic
              characterization of Lynch-like individuals"
}

@ARTICLE{Polidoro2013-xv,
  title   = "{EPIC-Italy} at {HuGeF}. {GSE51032}",
  author  = "Polidoro, S and Campanella, G and Krogh, V and Palli, D and
             Panico, S and Tumino, R and {Others}",
  journal = "Gene Expression Omnibus",
  year    =  2013
}

@ARTICLE{Davis2018-ha,
  title    = "The Encyclopedia of {DNA} elements ({ENCODE)}: data portal update",
  author   = "Davis, Carrie A and Hitz, Benjamin C and Sloan, Cricket A and
              Chan, Esther T and Davidson, Jean M and Gabdank, Idan and Hilton,
              Jason A and Jain, Kriti and Baymuradov, Ulugbek K and Narayanan,
              Aditi K and Onate, Kathrina C and Graham, Keenan and Miyasato,
              Stuart R and Dreszer, Timothy R and Strattan, J Seth and Jolanki,
              Otto and Tanaka, Forrest Y and Cherry, J Michael",
  abstract = "The Encyclopedia of DNA Elements (ENCODE) Data Coordinating
              Center has developed the ENCODE Portal database and website as
              the source for the data and metadata generated by the ENCODE
              Consortium. Two principles have motivated the design. First,
              experimental protocols, analytical procedures and the data
              themselves should be made publicly accessible through a coherent,
              web-based search and download interface. Second, the same
              interface should serve carefully curated metadata that record the
              provenance of the data and justify its interpretation in
              biological terms. Since its initial release in 2013 and in
              response to recommendations from consortium members and the wider
              community of scientists who use the Portal to access ENCODE data,
              the Portal has been regularly updated to better reflect these
              design principles. Here we report on these updates, including
              results from new experiments, uniformly-processed data from other
              projects, new visualization tools and more comprehensive metadata
              to describe experiments and analyses. Additionally, the Portal is
              now home to meta(data) from related projects including Genomics
              of Gene Regulation, Roadmap Epigenome Project, Model organism
              ENCODE (modENCODE) and modERN. The Portal now makes available
              over 13000 datasets and their accompanying metadata and can be
              accessed at: https://www.encodeproject.org/.",
  journal  = "Nucleic Acids Res.",
  volume   =  46,
  number   = "D1",
  pages    = "D794--D801",
  month    =  jan,
  year     =  2018,
  language = "en"
}

@MISC{Horvath2013-sk,
  title    = "{DNA} methylation age of human tissues and cell types",
  author   = "Horvath, Steve",
  journal  = "Genome Biology",
  volume   =  14,
  number   =  10,
  pages    = "R115",
  year     =  2013,
  keywords = "References from .bib"
}

@ARTICLE{Ventham2016-qj,
  title    = "Integrative epigenome-wide analysis demonstrates that {DNA}
              methylation may mediate genetic risk in inflammatory bowel
              disease",
  author   = "Ventham, N T and Kennedy, N A and Adams, A T and Kalla, R and
              Heath, S and O'Leary, K R and Drummond, H and {IBD BIOM
              consortium} and {IBD CHARACTER consortium} and Wilson, D C and
              Gut, I G and Nimmo, E R and Satsangi, J",
  abstract = "Epigenetic alterations may provide important insights into
              gene-environment interaction in inflammatory bowel disease (IBD).
              Here we observe epigenome-wide DNA methylation differences in 240
              newly-diagnosed IBD cases and 190 controls. These include 439
              differentially methylated positions (DMPs) and 5 differentially
              methylated regions (DMRs), which we study in detail using whole
              genome bisulphite sequencing. We replicate the top DMP (RPS6KA2)
              and DMRs (VMP1, ITGB2 and TXK) in an independent cohort. Using
              paired genetic and epigenetic data, we delineate methylation
              quantitative trait loci; VMP1/microRNA-21 methylation associates
              with two polymorphisms in linkage disequilibrium with a known IBD
              susceptibility variant. Separated cell data shows that
              IBD-associated hypermethylation within the TXK promoter region
              negatively correlates with gene expression in whole-blood and
              CD8+ T cells, but not other cell types. Thus, site-specific DNA
              methylation changes in IBD relate to underlying genotype and
              associate with cell-specific alteration in gene expression.",
  journal  = "Nat. Commun.",
  volume   =  7,
  pages    = "13507",
  month    =  nov,
  year     =  2016,
  language = "en"
}

@MISC{Basu_undated-vq,
  title   = "Reproducible research with jupyter notebooks",
  author  = "Basu, Arindam",
  journal = "Authorea"
}

@MISC{Zhang2019-br,
  title   = "Improved precision of epigenetic clock estimates across tissues
             and its implication for biological ageing",
  author  = "Zhang, Qian and Vallerga, Costanza L and Walker, Rosie M and Lin,
             Tian and Henders, Anjali K and Montgomery, Grant W and He, Ji and
             Fan, Dongsheng and Fowdar, Javed and Kennedy, Martin and Pitcher,
             Toni and Pearson, John and Halliday, Glenda and Kwok, John B and
             Hickie, Ian and Lewis, Simon and Anderson, Tim and Silburn, Peter
             A and Mellick, George D and Harris, Sarah E and Redmond, Paul and
             Murray, Alison D and Porteous, David J and Haley, Christopher S
             and Evans, Kathryn L and McIntosh, Andrew M and Yang, Jian and
             Gratten, Jacob and Marioni, Riccardo E and Wray, Naomi R and
             Deary, Ian J and McRae, Allan F and Visscher, Peter M",
  journal = "Genome Medicine",
  volume  =  11,
  number  =  1,
  year    =  2019
}

@ARTICLE{Tserel2015-ro,
  title    = "Age-related profiling of {DNA} methylation in {CD8+} {T} cells
              reveals changes in immune response and transcriptional regulator
              genes",
  author   = "Tserel, Liina and Kolde, Raivo and Limbach, Maia and Tretyakov,
              Konstantin and Kasela, Silva and Kisand, Kai and Saare, Mario and
              Vilo, Jaak and Metspalu, Andres and Milani, Lili and Peterson,
              P{\"a}rt",
  abstract = "Human ageing affects the immune system resulting in an overall
              decline in immunocompetence. Although all immune cells are
              affected during aging, the functional capacity of T cells is most
              influenced and is linked to decreased responsiveness to
              infections and impaired differentiation. We studied age-related
              changes in DNA methylation and gene expression in CD4+ and CD8+ T
              cells from younger and older individuals. We observed marked
              difference between T cell subsets, with increased number of
              methylation changes and higher methylome variation in CD8+ T
              cells with age. The majority of age-related hypermethylated sites
              were located at CpG islands of silent genes and enriched for
              repressive histone marks. Specifically, in CD8+ T cell subset we
              identified strong inverse correlation between methylation and
              expression levels in genes associated with T cell mediated immune
              response (LGALS1, IFNG, CCL5, GZMH, CCR7, CD27 and CD248) and
              differentiation (SATB1, TCF7, BCL11B and RUNX3). Our results thus
              suggest the link between age-related epigenetic changes and
              impaired T cell function.",
  journal  = "Sci. Rep.",
  volume   =  5,
  pages    = "13107",
  month    =  aug,
  year     =  2015,
  language = "en"
}

@ARTICLE{Carrieri2004-by,
  title    = "The {G/C915} polymorphism of transforming growth factor beta1 is
              associated with human longevity: a study in Italian centenarians",
  author   = "Carrieri, Giuseppina and Marzi, Erika and Olivieri, Fabiola and
              Marchegiani, Francesca and Cavallone, Luca and Cardelli, Maurizio
              and Giovagnetti, Simona and Stecconi, Rosalia and Molendini,
              Cinzia and Trapassi, Chiara and De Benedictis, Giovanna and
              Kletsas, Dimitri and Franceschi, Claudio",
  abstract = "Sequence variations in a variety of pro- or anti-inflammatory
              cytokine genes have been found to influence successful aging and
              longevity. Because of the role played by the transforming growth
              factor beta1 (TGF-beta1) cytokine in inflammation and regulation
              of immune responses, the variability of the TGF-beta1 gene may
              affect longevity by playing a role in inflamm-aging. Two
              polymorphisms, G/A -800 and C/T -509, located in the 5' region,
              and two missense polymorphisms, T/C 869 and G/C 915 which change
              (Leu > Pro)10 and (Arg > Pro)25, respectively, located in the
              signal peptide, were analysed in 419 subjects from Northern and
              Central Italy, including 172 centenarians and 247 younger
              controls. In addition, the effects of the TGF-beta1 genetic
              variability on plasma levels of the biologically active form
              (naturally processed) of this cytokine were studied in 143
              randomly selected subjects, including 73 centenarians.
              Significant differences were found at the +915 site as far as the
              C allele and GC genotype were concerned, both of them being lower
              in centenarians than in young controls (P=0.034 and 0.028,
              respectively), but none of the other tested genetic variants was
              significantly different between centenarians and controls.
              Moreover, a particular haplotype combination (G -800/C -509/C
              869/C 915) was notably lower in centenarians than in younger
              individuals (P=0.007). Finally, active TGF-beta1 plasma levels
              were significantly increased in the elderly group, but no
              relationship with TGF-beta1 genotypes was observed. These results
              suggest that, at least in this population, the variability of the
              TGF-beta1 gene influences longevity and that the age-related
              increase in plasma levels of active TGF-beta1 seems not to be
              genetically regulated.",
  journal  = "Aging Cell",
  volume   =  3,
  number   =  6,
  pages    = "443--448",
  month    =  dec,
  year     =  2004,
  language = "en"
}

@MISC{Hunter2007-nq,
  title   = "Matplotlib: A {2D} Graphics Environment",
  author  = "Hunter, John D",
  journal = "Computing in Science \& Engineering",
  volume  =  9,
  number  =  3,
  pages   = "90--95",
  year    =  2007
}

@ARTICLE{Chuang2017-nk,
  title    = "Parkinson's disease is associated with {DNA} methylation levels
              in human blood and saliva",
  author   = "Chuang, Yu-Hsuan and Paul, Kimberly C and Bronstein, Jeff M and
              Bordelon, Yvette and Horvath, Steve and Ritz, Beate",
  abstract = "BACKGROUND: Several articles suggest that DNA methylation levels
              in blood relate to Parkinson's disease (PD) but there is a need
              for a large-scale study that involves suitable population based
              controls. The purposes of the study were: (1) to study whether PD
              status is associated with DNA methylation levels in blood/saliva;
              (2) to study whether observed associations relate to blood cell
              types; and (3) to characterize genome-wide significant markers
              (``CpGs'') and clusters of CpGs (co-methylation modules) in terms
              of biological pathways. METHODS: In a population-based case
              control study of PD, we studied blood samples from 335 PD cases
              and 237 controls and saliva samples from another 128 cases and
              131 controls. DNA methylation data were generated from over
              486,000 CpGs using the Illumina Infinium array. We identified
              modules of CpGs (clusters) using weighted correlation network
              analysis (WGCNA). RESULTS: Our cross-sectional analysis of blood
              identified 82 genome-wide significant CpGs (including cg02489202
              in LARS2 p = 8.3 $\times$ 10-11 and cg04772575 in ABCB9 p = 4.3
              $\times$ 10-10). Three out of six PD related co-methylation
              modules in blood were significantly enriched with immune system
              related genes. Our analysis of saliva identified five significant
              CpGs. PD-related CpGs are located near genes that relate to
              mitochondrial function, neuronal projection, cytoskeleton
              organization, systemic immune response, and iron handling.
              CONCLUSIONS: This study demonstrates that: (1) PD status has a
              profound association with DNA methylation levels in blood and
              saliva; and (2) the most significant PD-related changes reflect
              changes in blood cell composition. Overall, this study highlights
              the role of the immune system in PD etiology but future research
              will need to address the causal structure of these relationships.",
  journal  = "Genome Med.",
  volume   =  9,
  number   =  1,
  pages    = "76",
  month    =  aug,
  year     =  2017,
  keywords = "Bioinformatics; Blood cell counts; Cytoskeleton; DNA methylation;
              Epigenomics; Immune system; Mitochondrial dysfunction;
              Parkinson's disease; Saliva; WGCNA",
  language = "en"
}

@MISC{Perna2016-pi,
  title   = "Epigenetic age acceleration predicts cancer, cardiovascular, and
             all-cause mortality in a German case cohort",
  author  = "Perna, Laura and Zhang, Yan and Mons, Ute and Holleczek, Bernd and
             Saum, Kai-Uwe and Brenner, Hermann",
  journal = "Clinical Epigenetics",
  volume  =  8,
  number  =  1,
  year    =  2016
}

@ARTICLE{Snir2016-dv,
  title    = "A Statistical Framework to Identify Deviation from Time Linearity
              in Epigenetic Aging",
  author   = "Snir, Sagi and vonHoldt, Bridgett M and Pellegrini, Matteo",
  abstract = "In multiple studies DNA methylation has proven to be an accurate
              biomarker of age. To develop these biomarkers, the methylation of
              multiple CpG sites is typically linearly combined to predict
              chronological age. By contrast, in this study we apply the
              Universal PaceMaker (UPM) model to investigate changes in DNA
              methylation during aging. The UPM was initially developed to
              study rate acceleration/deceleration in sequence evolution.
              Rather than identifying which linear combinations of sites
              predicts age, the UPM models the rates of change of multiple CpG
              sites, as well as their starting methylation levels, and
              estimates the age of each individual to optimize the model fit.
              We refer to the estimated age as the ``epigenetic age'', which is
              in contrast to the known chronological age of each individual. We
              construct a statistical framework and devise an algorithm to
              determine whether a genomic pacemaker is in effect (i.e rates of
              change vary with age). The decision is made by comparing two
              competing likelihood based models, the molecular clock (MC) and
              UPM. For the molecular clock model, we use the known
              chronological age of each individual and fit the methylation
              rates at multiple sites, and express the problem as a linear
              least squares and solve it in polynomial time. For the UPM case,
              the search space is larger as we are fitting both the epigenetic
              age of each individual as well as the rates for each site, yet we
              succeed to reduce the problem to the space of individuals and
              polynomial in the more significant space-the methylated sites. We
              first tested our algorithm on simulated data to elucidate the
              factors affecting the identification of the pacemaker model. We
              find that, provided with enough data, our algorithm is capable of
              identifying a pacemaker even when a weak signal is present in the
              data. Based on these results, we applied our method to DNA
              methylation data from human blood from individuals of various
              ages. Although the improvement in variance across sites between
              the UPM and MC was small, the results suggest that the existence
              of a pacemaker is highly significant. The PaceMaker results also
              suggest a decay in the rate of change in DNA methylation with
              age.",
  journal  = "PLoS Comput. Biol.",
  volume   =  12,
  number   =  11,
  pages    = "e1005183",
  month    =  nov,
  year     =  2016,
  language = "en"
}

@ARTICLE{Waskom2021-gj,
  title     = "seaborn: statistical data visualization",
  author    = "Waskom, Michael",
  journal   = "J. Open Source Softw.",
  publisher = "The Open Journal",
  volume    =  6,
  number    =  60,
  pages     = "3021",
  month     =  apr,
  year      =  2021,
  copyright = "http://creativecommons.org/licenses/by/4.0/"
}

@ARTICLE{Paris2016-fo,
  title    = "Smad4 restricts differentiation to promote expansion of satellite
              cell derived progenitors during skeletal muscle regeneration",
  author   = "Paris, Nicole D and Soroka, Andrew and Klose, Alanna and Liu,
              Wenxuan and Chakkalakal, Joe V",
  abstract = "Skeletal muscle regenerative potential declines with age, in part
              due to deficiencies in resident stem cells (satellite cells, SCs)
              and derived myogenic progenitors (MPs); however, the factors
              responsible for this decline remain obscure. TGF$\beta$
              superfamily signaling is an inhibitor of myogenic
              differentiation, with elevated activity in aged skeletal muscle.
              Surprisingly, we find reduced expression of Smad4, the downstream
              cofactor for canonical TGF$\beta$ superfamily signaling, and the
              target Id1 in aged SCs and MPs during regeneration. Specific
              deletion of Smad4 in adult mouse SCs led to increased propensity
              for terminal myogenic commitment connected to impaired
              proliferative potential. Furthermore, SC-specific Smad4
              disruption compromised adult skeletal muscle regeneration.
              Finally, loss of Smad4 in aged SCs did not promote aged skeletal
              muscle regeneration. Therefore, SC-specific reduction of Smad4 is
              a feature of aged regenerating skeletal muscle and Smad4 is a
              critical regulator of SC and MP amplification during skeletal
              muscle regeneration.",
  journal  = "Elife",
  volume   =  5,
  month    =  nov,
  year     =  2016,
  keywords = "Smad4; TGFB; aging; developmental biology; mouse; muscle stem
              cells; sarcopenia; satellite cells; stem cells",
  language = "en"
}

@ARTICLE{Butcher2017-oz,
  title    = "{CHARGE} and Kabuki Syndromes: {Gene-Specific} {DNA} Methylation
              Signatures Identify Epigenetic Mechanisms Linking These
              Clinically Overlapping Conditions",
  author   = "Butcher, Darci T and Cytrynbaum, Cheryl and Turinsky, Andrei L
              and Siu, Michelle T and Inbar-Feigenberg, Michal and
              Mendoza-Londono, Roberto and Chitayat, David and Walker, Susan
              and Machado, Jerry and Caluseriu, Oana and Dupuis, Lucie and
              Grafodatskaya, Daria and Reardon, William and Gilbert-Dussardier,
              Brigitte and Verloes, Alain and Bilan, Frederic and Milunsky,
              Jeff M and Basran, Raveen and Papsin, Blake and Stockley, Tracy L
              and Scherer, Stephen W and Choufani, Sanaa and Brudno, Michael
              and Weksberg, Rosanna",
  abstract = "Epigenetic dysregulation has emerged as a recurring mechanism in
              the etiology of neurodevelopmental disorders. Two such disorders,
              CHARGE and Kabuki syndromes, result from loss of function
              mutations in chromodomain helicase DNA-binding protein 7
              (CHD7LOF) and lysine (K) methyltransferase 2D (KMT2DLOF),
              respectively. Although these two syndromes are clinically
              distinct, there is significant phenotypic overlap. We therefore
              expected that epigenetically driven developmental pathways
              regulated by CHD7 and KMT2D would overlap and that DNA
              methylation (DNAm) alterations downstream of the mutations in
              these genes would identify common target genes, elucidating a
              mechanistic link between these two conditions, as well as
              specific target genes for each disorder. Genome-wide DNAm
              profiles in individuals with CHARGE and Kabuki syndromes with
              CHD7LOF or KMT2DLOF identified distinct sets of DNAm differences
              in each of the disorders, which were used to generate two unique,
              highly specific and sensitive DNAm signatures. These DNAm
              signatures were able to differentiate pathogenic mutations in
              these two genes from controls and from each other. Analysis of
              the DNAm targets in each gene-specific signature identified both
              common gene targets, including homeobox A5 (HOXA5), which could
              account for some of the clinical overlap in CHARGE and Kabuki
              syndromes, as well as distinct gene targets. Our findings
              demonstrate how characterization of the epigenome can contribute
              to our understanding of disease pathophysiology for epigenetic
              disorders, paving the way for explorations of novel therapeutics.",
  journal  = "Am. J. Hum. Genet.",
  volume   =  100,
  number   =  5,
  pages    = "773--788",
  month    =  may,
  year     =  2017,
  keywords = "CHARGE syndrome; DNA methylation; Epigenetics; Kabuki syndrome;
              chromodomain helicase DNA-binding protein 7 (CHD7); lysine (K)
              methyltransferase 2D (KMT2D)",
  language = "en"
}

@ARTICLE{Marioni2015-sn,
  title    = "{DNA} methylation age of blood predicts all-cause mortality in
              later life",
  author   = "Marioni, Riccardo E and Shah, Sonia and McRae, Allan F and Chen,
              Brian H and Colicino, Elena and Harris, Sarah E and Gibson, Jude
              and Henders, Anjali K and Redmond, Paul and Cox, Simon R and
              Pattie, Alison and Corley, Janie and Murphy, Lee and Martin,
              Nicholas G and Montgomery, Grant W and Feinberg, Andrew P and
              Fallin, M Daniele and Multhaup, Michael L and Jaffe, Andrew E and
              Joehanes, Roby and Schwartz, Joel and Just, Allan C and Lunetta,
              Kathryn L and Murabito, Joanne M and Starr, John M and Horvath,
              Steve and Baccarelli, Andrea A and Levy, Daniel and Visscher,
              Peter M and Wray, Naomi R and Deary, Ian J",
  abstract = "BACKGROUND: DNA methylation levels change with age. Recent
              studies have identified biomarkers of chronological age based on
              DNA methylation levels. It is not yet known whether DNA
              methylation age captures aspects of biological age. RESULTS: Here
              we test whether differences between people's chronological ages
              and estimated ages, DNA methylation age, predict all-cause
              mortality in later life. The difference between DNA methylation
              age and chronological age ($\Delta$age) was calculated in four
              longitudinal cohorts of older people. Meta-analysis of
              proportional hazards models from the four cohorts was used to
              determine the association between $\Delta$age and mortality. A
              5-year higher $\Delta$age is associated with a 21\% higher
              mortality risk, adjusting for age and sex. After further
              adjustments for childhood IQ, education, social class,
              hypertension, diabetes, cardiovascular disease, and APOE e4
              status, there is a 16\% increased mortality risk for those with a
              5-year higher $\Delta$age. A pedigree-based heritability analysis
              of $\Delta$age was conducted in a separate cohort. The
              heritability of $\Delta$age was 0.43. CONCLUSIONS: DNA
              methylation-derived measures of accelerated aging are heritable
              traits that predict mortality independently of health status,
              lifestyle factors, and known genetic factors.",
  journal  = "Genome Biol.",
  volume   =  16,
  pages    = "25",
  month    =  jan,
  year     =  2015,
  language = "en"
}

@ARTICLE{Xiong2020-fa,
  title    = "{EWAS} Data Hub: a resource of {DNA} methylation array data and
              metadata",
  author   = "Xiong, Zhuang and Li, Mengwei and Yang, Fei and Ma, Yingke and
              Sang, Jian and Li, Rujiao and Li, Zhaohua and Zhang, Zhang and
              Bao, Yiming",
  abstract = "Epigenome-Wide Association Study (EWAS) has become an effective
              strategy to explore epigenetic basis of complex traits. Over the
              past decade, a large amount of epigenetic data, especially those
              sourced from DNA methylation array, has been accumulated as the
              result of numerous EWAS projects. We present EWAS Data Hub
              (https://bigd.big.ac.cn/ewas/datahub), a resource for collecting
              and normalizing DNA methylation array data as well as archiving
              associated metadata. The current release of EWAS Data Hub
              integrates a comprehensive collection of DNA methylation array
              data from 75 344 samples and employs an effective normalization
              method to remove batch effects among different datasets.
              Accordingly, taking advantages of both massive high-quality DNA
              methylation data and standardized metadata, EWAS Data Hub
              provides reference DNA methylation profiles under different
              contexts, involving 81 tissues/cell types (that contain 25 brain
              parts and 25 blood cell types), six ancestry categories, and 67
              diseases (including 39 cancers). In summary, EWAS Data Hub bears
              great promise to aid the retrieval and discovery of
              methylation-based biomarkers for phenotype characterization,
              clinical treatment and health care.",
  journal  = "Nucleic Acids Res.",
  volume   =  48,
  number   = "D1",
  pages    = "D890--D895",
  month    =  jan,
  year     =  2020,
  language = "en"
}

@ARTICLE{McCartney2019-qi,
  title    = "An epigenome-wide association study of sex-specific chronological
              ageing",
  author   = "McCartney, Daniel L and Zhang, Futao and Hillary, Robert F and
              Zhang, Qian and Stevenson, Anna J and Walker, Rosie M and
              Bermingham, Mairead L and Boutin, Thibaud and Morris, Stewart W
              and Campbell, Archie and Murray, Alison D and Whalley, Heather C
              and Porteous, David J and Hayward, Caroline and Evans, Kathryn L
              and Chandra, Tamir and Deary, Ian J and McIntosh, Andrew M and
              Yang, Jian and Visscher, Peter M and McRae, Allan F and Marioni,
              Riccardo E",
  abstract = "BACKGROUND: Advanced age is associated with cognitive and
              physical decline and is a major risk factor for a multitude of
              disorders. There is also a gap in life expectancy between males
              and females. DNA methylation differences have been shown to be
              associated with both age and sex. Here, we investigate age-by-sex
              differences in blood-based DNA methylation in an unrelated cohort
              of 2586 individuals between the ages of 18 and 87 years, with
              replication in a further 4450 individuals between the ages of 18
              and 93 years. METHODS: Linear regression models were applied,
              with stringent genome-wide significance thresholds (p < 3.6
              $\times$ 10) used in both the discovery and replication data. A
              second, highly conservative mixed linear model method that better
              controls the false-positive rate was also applied, using the same
              genome-wide significance thresholds. RESULTS: Using the linear
              regression method, 52 autosomal and 597 X-linked CpG sites,
              mapping to 251 unique genes, replicated with concordant effect
              size directions in the age-by-sex interaction analysis. The site
              with the greatest difference mapped to GAGE10, an X-linked gene.
              Here, DNA methylation levels remained stable across the male
              adult age range (DNA methylation by age r = 0.02) but decreased
              across female adult age range (DNA methylation by age r = -
              0.61). One site (cg23722529) with a significant age-by-sex
              interaction also had a quantitative trait locus (rs17321482) that
              is a genome-wide significant variant for prostate cancer. The
              mixed linear model method identified 11 CpG sites associated with
              the age-by-sex interaction. CONCLUSION: The majority of
              differences in age-associated DNA methylation trajectories
              between sexes are present on the X chromosome. Several of these
              differences occur within genes that have been implicated in
              sexually dimorphic traits.",
  journal  = "Genome Med.",
  volume   =  12,
  number   =  1,
  pages    = "1",
  month    =  dec,
  year     =  2019,
  keywords = "Ageing; DNA methylation; Generation Scotland; Sexual dimorphism;
              X chromosome",
  language = "en"
}

@ARTICLE{Trenerry2008-kj,
  title    = "Exercise-induced activation of {STAT3} signaling is increased
              with age",
  author   = "Trenerry, Marissa K and Carey, Kate A and Ward, Alister C and
              Farnfield, Michelle M and Cameron-Smith, David",
  abstract = "Activation of the transcription factor signal transducers and
              activators of transcription (STAT) 3 is common to many
              inflammatory cytokines and growth factors, with recent evidence
              of involvement in skeletal muscle regeneration. The purpose of
              this study was to determine whether STAT3 signaling activation is
              regulated differentially, at rest and following intense
              resistance exercise, in aged human skeletal muscle. Skeletal
              muscle biopsies were harvested from healthy younger (n = 11, 20.4
              +/- 0.8 years) and older men (n = 10, 67.4 +/- 1.3 years) under
              resting conditions and 2 h after the completion of resistance
              exercise. No differences were evident at rest, whereas the
              phosphorylation of STAT3 was significantly increased in old
              (23-fold) compared to young (5-fold) subjects after exercise.
              This correlated with significantly higher induction of the STAT3
              target genes including; interleukin-6 (IL-6), JUNB, c-MYC, and
              suppressor of cytokine signaling (SOCS) 3 mRNA in older subjects
              following exercise. Despite increased SOCS3 mRNA, cellular
              protein abundance was suppressed. SOCS3 protein is an important
              negative regulator of STAT3 activation and cytokine signaling.
              Thus, in aged human muscle, elevated responsiveness of the STAT3
              signaling pathway and suppressed SOCS3 protein are evident
              following resistance exercise. These data suggest that enhanced
              STAT3 signaling responsiveness to proinflammatory factors may
              impact on mechanisms of muscle repair and regeneration.",
  journal  = "Rejuvenation Res.",
  volume   =  11,
  number   =  4,
  pages    = "717--724",
  month    =  aug,
  year     =  2008,
  language = "en"
}

@ARTICLE{Lu2019-lg,
  title     = "{DNA} methylation {GrimAge} strongly predicts lifespan and
               healthspan",
  author    = "Lu, Ake T and Quach, Austin and Wilson, James G and Reiner, Alex
               P and Aviv, Abraham and Raj, Kenneth and Hou, Lifang and
               Baccarelli, Andrea A and Li, Yun and Stewart, James D and
               Whitsel, Eric A and Assimes, Themistocles L and Ferrucci, Luigi
               and Horvath, Steve",
  abstract  = "It was unknown whether plasma protein levels can be estimated
               based on DNA methylation (DNAm) levels, and if so, how the
               resulting surrogates can be consolidated into a powerful
               predictor of lifespan. We present here, seven DNAm-based
               estimators of plasma proteins including those of plasminogen
               activator inhibitor 1 (PAI-1) and growth differentiation factor
               15. The resulting predictor of lifespan, DNAm GrimAge (in units
               of years), is a composite biomarker based on the seven DNAm
               surrogates and a DNAm-based estimator of smoking pack-years.
               Adjusting DNAm GrimAge for chronological age generated novel
               measure of epigenetic age acceleration, AgeAccelGrim.Using large
               scale validation data from thousands of individuals, we
               demonstrate that DNAm GrimAge stands out among existing
               epigenetic clocks in terms of its predictive ability for
               time-to-death (Cox regression P=2.0E-75), time-to-coronary heart
               disease (Cox P=6.2E-24), time-to-cancer (P= 1.3E-12), its strong
               relationship with computed tomography data for fatty
               liver/excess visceral fat, and age-at-menopause (P=1.6E-12).
               AgeAccelGrim is strongly associated with a host of age-related
               conditions including comorbidity count (P=3.45E-17). Similarly,
               age-adjusted DNAm PAI-1 levels are associated with lifespan
               (P=5.4E-28), comorbidity count (P= 7.3E-56) and type 2 diabetes
               (P=2.0E-26). These DNAm-based biomarkers show the expected
               relationship with lifestyle factors including healthy diet and
               educational attainment.Overall, these epigenetic biomarkers are
               expected to find many applications including human anti-aging
               studies.",
  journal   = "Aging",
  publisher = "Impact Journals, LLC",
  volume    =  11,
  number    =  2,
  pages     = "303--327",
  month     =  jan,
  year      =  2019,
  keywords  = "DNA methylation; epigenetics; mortality; proteomics",
  language  = "en"
}

@ARTICLE{Damaso2020-gd,
  title    = "Comprehensive Constitutional Genetic and Epigenetic
              Characterization of {Lynch-Like} Individuals",
  author   = "D{\'a}maso, Estela and Gonz{\'a}lez-Acosta, Maribel and
              Vargas-Parra, Gardenia and Navarro, Matilde and Balma{\~n}a,
              Judith and Ramon Y Cajal, Teresa and Tuset, Noem{\'\i} and
              Thompson, Bryony A and Mar{\'\i}n, F{\'a}tima and Fern{\'a}ndez,
              Anna and G{\'o}mez, Carolina and Velasco, {\`A}ngela and Solanes,
              Ares and Iglesias, S{\'\i}lvia and Urgel, Gisela and L{\'o}pez,
              Consol and Del Valle, Jes{\'u}s and Campos, Olga and Santacana,
              Maria and Matias-Guiu, Xavier and L{\'a}zaro, Conxi and Valle,
              Laura and Brunet, Joan and Pineda, Marta and Capell{\'a}, Gabriel",
  abstract = "The causal mechanism for cancer predisposition in Lynch-like
              syndrome (LLS) remains unknown. Our aim was to elucidate the
              constitutional basis of mismatch repair (MMR) deficiency in LLS
              patients throughout a comprehensive (epi)genetic analysis. One
              hundred and fifteen LLS patients harboring MMR-deficient tumors
              and no germline MMR mutations were included. Mutational analysis
              of 26 colorectal cancer (CRC)-associated genes was performed.
              Pathogenicity of MMR variants was assessed by splicing and
              multifactorial likelihood analyses. Genome-wide methylome
              analysis was performed by the Infinium Human Methylation 450K
              Bead Chip. The multigene panel analysis revealed the presence of
              two MMR gene truncating mutations not previously found. Of a
              total of 15 additional MMR variants identified, five -present in
              6 unrelated individuals- were reclassified as pathogenic. In
              addition, 13 predicted deleterious variants in other
              CRC-predisposing genes were found in 12 probands. Methylome
              analysis detected one constitutional MLH1 epimutation, but no
              additional differentially methylated regions were identified in
              LLS compared to LS patients or cancer-free individuals. In
              conclusion, the use of an ad-hoc designed gene panel combined
              with pathogenicity assessment of variants allowed the
              identification of deleterious MMR mutations as well as new LLS
              candidate causal genes. Constitutional epimutations in
              non-LS-associated genes are not responsible for LLS.",
  journal  = "Cancers",
  volume   =  12,
  number   =  7,
  month    =  jul,
  year     =  2020,
  keywords = "Lynch syndrome; Lynch-like syndrome; cancer genes panel;
              epimutation; methylation; mismatch repair; next generation
              sequencing; variant of unknown significance",
  language = "en"
}

@ARTICLE{Virtanen2020-wt,
  title    = "{SciPy} 1.0: fundamental algorithms for scientific computing in
              Python",
  author   = "Virtanen, Pauli and Gommers, Ralf and Oliphant, Travis E and
              Haberland, Matt and Reddy, Tyler and Cournapeau, David and
              Burovski, Evgeni and Peterson, Pearu and Weckesser, Warren and
              Bright, Jonathan and van der Walt, St{\'e}fan J and Brett,
              Matthew and Wilson, Joshua and Millman, K Jarrod and Mayorov,
              Nikolay and Nelson, Andrew R J and Jones, Eric and Kern, Robert
              and Larson, Eric and Carey, C J and Polat, {\.I}lhan and Feng, Yu
              and Moore, Eric W and VanderPlas, Jake and Laxalde, Denis and
              Perktold, Josef and Cimrman, Robert and Henriksen, Ian and
              Quintero, E A and Harris, Charles R and Archibald, Anne M and
              Ribeiro, Ant{\^o}nio H and Pedregosa, Fabian and van Mulbregt,
              Paul and Vijaykumar, Aditya and Bardelli, Alessandro Pietro and
              Rothberg, Alex and Hilboll, Andreas and Kloeckner, Andreas and
              Scopatz, Anthony and Lee, Antony and Rokem, Ariel and Woods, C
              Nathan and Fulton, Chad and Masson, Charles and
              H{\"a}ggstr{\"o}m, Christian and Fitzgerald, Clark and Nicholson,
              David A and Hagen, David R and Pasechnik, Dmitrii V and Olivetti,
              Emanuele and Martin, Eric and Wieser, Eric and Silva, Fabrice and
              Lenders, Felix and Wilhelm, Florian and Young, G and Price, Gavin
              A and Ingold, Gert-Ludwig and Allen, Gregory E and Lee, Gregory R
              and Audren, Herv{\'e} and Probst, Irvin and Dietrich, J{\"o}rg P
              and Silterra, Jacob and Webber, James T and Slavi{\v c}, Janko
              and Nothman, Joel and Buchner, Johannes and Kulick, Johannes and
              Sch{\"o}nberger, Johannes L and de Miranda Cardoso, Jos{\'e}
              Vin{\'\i}cius and Reimer, Joscha and Harrington, Joseph and
              Rodr{\'\i}guez, Juan Luis Cano and Nunez-Iglesias, Juan and
              Kuczynski, Justin and Tritz, Kevin and Thoma, Martin and
              Newville, Matthew and K{\"u}mmerer, Matthias and Bolingbroke,
              Maximilian and Tartre, Michael and Pak, Mikhail and Smith,
              Nathaniel J and Nowaczyk, Nikolai and Shebanov, Nikolay and
              Pavlyk, Oleksandr and Brodtkorb, Per A and Lee, Perry and
              McGibbon, Robert T and Feldbauer, Roman and Lewis, Sam and
              Tygier, Sam and Sievert, Scott and Vigna, Sebastiano and
              Peterson, Stefan and More, Surhud and Pudlik, Tadeusz and Oshima,
              Takuya and Pingel, Thomas J and Robitaille, Thomas P and Spura,
              Thomas and Jones, Thouis R and Cera, Tim and Leslie, Tim and
              Zito, Tiziano and Krauss, Tom and Upadhyay, Utkarsh and
              Halchenko, Yaroslav O and V{\'a}zquez-Baeza, Yoshiki and {SciPy
              1.0 Contributors}",
  abstract = "SciPy is an open-source scientific computing library for the
              Python programming language. Since its initial release in 2001,
              SciPy has become a de facto standard for leveraging scientific
              algorithms in Python, with over 600 unique code contributors,
              thousands of dependent packages, over 100,000 dependent
              repositories and millions of downloads per year. In this work, we
              provide an overview of the capabilities and development practices
              of SciPy 1.0 and highlight some recent technical developments.",
  journal  = "Nat. Methods",
  month    =  feb,
  year     =  2020
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Carlson2009-uz,
  title     = "Relative roles of {TGF-{\^I}1} and Wnt in the systemic
               regulation and aging of satellite cell responses",
  author    = "Carlson, Morgan E and Conboy, Michael J and Hsu, Michael and
               Barchas, Laurel and Jeong, Jaemin and Agrawal, Anshu and Mikels,
               Amanda J and Agrawal, Smita and Schaffer, David V and Conboy,
               Irina M",
  abstract  = "Muscle stem (satellite) cells are relatively resistant to
               cell-autonomous aging. Instead, their endogenous signaling
               profile and regenerative capacity is strongly influenced by the
               aged P-Smad3, differentiated niche, and by the aged circulation.
               With respect to muscle fibers, we previously established that a
               shift from active Notch to excessive transforming growth
               factor-beta (TGF-beta) induces CDK inhibitors in satellite
               cells, thereby interfering with productive myogenic responses.
               In contrast, the systemic inhibitor of muscle repair, elevated
               in old sera, was suggested to be Wnt. Here, we examined the
               age-dependent myogenic activity of sera TGF-beta1, and its
               potential cross-talk with systemic Wnt. We found that sera
               TGF-beta1 becomes elevated within aged humans and mice, while
               systemic Wnt remained undetectable in these species. Wnt also
               failed to inhibit satellite cell myogenicity, while TGF-beta1
               suppressed regenerative potential in a biphasic fashion.
               Intriguingly, young levels of TGF-beta1 were inhibitory and
               young sera suppressed myogenesis if TGF-beta1 was activated. Our
               data suggest that platelet-derived sera TGF-beta1 levels, or
               endocrine TGF-beta1 levels, do not explain the age-dependent
               inhibition of muscle regeneration by this cytokine. In vivo,
               TGF-beta neutralizing antibody, or a soluble decoy, failed to
               reduce systemic TGF-beta1 and rescue myogenesis in old mice.
               However, muscle regeneration was improved by the systemic
               delivery of a TGF-beta receptor kinase inhibitor, which
               attenuated TGF-beta signaling in skeletal muscle. Summarily,
               these findings argue against the endocrine path of a
               TGF-beta1-dependent block on muscle regeneration, identify
               physiological modalities of age-imposed changes in TGF-beta1,
               and introduce new therapeutic strategies for the broad
               restoration of aged organ repair.",
  journal   = "Aging Cell",
  publisher = "Wiley",
  volume    =  8,
  number    =  6,
  pages     = "676--689",
  month     =  dec,
  year      =  2009,
  language  = "en"
}

@ARTICLE{ENCODE_Project_Consortium2012-oe,
  title    = "An integrated encyclopedia of {DNA} elements in the human genome",
  author   = "{ENCODE Project Consortium}",
  abstract = "The human genome encodes the blueprint of life, but the function
              of the vast majority of its nearly three billion bases is
              unknown. The Encyclopedia of DNA Elements (ENCODE) project has
              systematically mapped regions of transcription, transcription
              factor association, chromatin structure and histone modification.
              These data enabled us to assign biochemical functions for 80\% of
              the genome, in particular outside of the well-studied
              protein-coding regions. Many discovered candidate regulatory
              elements are physically associated with one another and with
              expressed genes, providing new insights into the mechanisms of
              gene regulation. The newly identified elements also show a
              statistical correspondence to sequence variants linked to human
              disease, and can thereby guide interpretation of this variation.
              Overall, the project provides new insights into the organization
              and regulation of our genes and genome, and is an expansive
              resource of functional annotations for biomedical research.",
  journal  = "Nature",
  volume   =  489,
  number   =  7414,
  pages    = "57--74",
  month    =  sep,
  year     =  2012,
  language = "en"
}

@ARTICLE{Rocchi2021-od,
  title    = "{REST/NRSF} deficiency impairs autophagy and leads to cellular
              senescence in neurons",
  author   = "Rocchi, Anna and Carminati, Emanuele and De Fusco, Antonio and
              Kowalska, Jagoda Aleksandra and Floss, Thomas and Benfenati,
              Fabio",
  abstract = "During aging, brain performances decline. Cellular senescence is
              one of the aging drivers and a key feature of a variety of human
              age-related disorders. The transcriptional repressor
              RE1-silencing transcription factor (REST) has been associated
              with aging and higher risk of neurodegenerative disorders.
              However, how REST contributes to the senescence program and
              functional impairment remains largely unknown. Here, we report
              that REST is essential to prevent the senescence phenotype in
              primary mouse neurons. REST deficiency causes failure of
              autophagy and loss of proteostasis, increased oxidative stress,
              and higher rate of cell death. Re-establishment of autophagy
              reverses the main hallmarks of senescence. Our data indicate that
              REST has a protective role in physiological aging by regulating
              the autophagic flux and the senescence program in neurons, with
              implications for neurological disorders associated with aging.",
  journal  = "Aging Cell",
  volume   =  20,
  number   =  10,
  pages    = "e13471",
  month    =  oct,
  year     =  2021,
  keywords = "REST/NRSF; autophagy; mitochondria; neurons; oxidative stress;
              rapamycin; senescence; trehalose",
  language = "en"
}

@ARTICLE{Snir2020-tc,
  title    = "Epigenetic pacemaker: closed form algebraic solutions",
  author   = "Snir, Sagi",
  abstract = "BACKGROUND: DNA methylation is widely used as a biomarker in
              crucial medical applications as well as for human age prediction
              of very high accuracy. This biomarker is based on the methylation
              status of several hundred CpG sites. In a recent line of
              publications we have adapted a versatile concept from
              evolutionary biology - the Universal Pacemaker (UPM) - to the
              setting of epigenetic aging and denoted it the Epigenetic
              PaceMaker (EPM). The EPM, as opposed to other epigenetic clocks,
              is not confined to specific pattern of aging, and the epigenetic
              age of the individual is inferred independently of other
              individuals. This allows an explicit modeling of aging trends, in
              particular non linear relationship between chronological and
              epigenetic age. In one of these recent works, we have presented
              an algorithmic improvement based on a two-step conditional
              expectation maximization (CEM) algorithm to arrive at a critical
              point on the likelihood surface. The algorithm alternates between
              a time step and a site step while advancing on the likelihood
              surface. RESULTS: Here we introduce non trivial improvements to
              these steps that are essential for analyzing data sets of
              realistic magnitude in a manageable time and space. These
              structural improvements are based on insights from linear algebra
              and symbolic algebra tools, providing us greater understanding of
              the degeneracy of the complex problem space. This understanding
              in turn, leads to the complete elimination of the bottleneck of
              cumbersome matrix multiplication and inversion, yielding a fast
              closed form solution in both steps of the CEM.In the experimental
              results part, we compare the CEM algorithm over several data sets
              and demonstrate the speedup obtained by the closed form
              solutions. Our results support the theoretical analysis of this
              improvement. CONCLUSIONS: These improvements enable us to
              increase substantially the scale of inputs analyzed by the
              method, allowing us to apply the new approach to data sets that
              could not be analyzed before.",
  journal  = "BMC Genomics",
  volume   =  21,
  number   = "Suppl 2",
  pages    = "257",
  month    =  apr,
  year     =  2020,
  keywords = "Conditional Expectation Maximization; Epigenetics; Matrix
              Multiplication; Symbolic Algebra; Universal PaceMaker",
  language = "en"
}

@ARTICLE{Voisin2015-lh,
  title    = "Many obesity-associated {SNPs} strongly associate with {DNA}
              methylation changes at proximal promoters and enhancers",
  author   = "Voisin, Sarah and Alm{\'e}n, Markus S{\"a}llman and
              Zheleznyakova, Galina Y and Lundberg, Lina and Zarei, Sanaz and
              Castillo, Sandra and Eriksson, Fia Ence and Nilsson, Emil K and
              Bl{\"u}her, Matthias and B{\"o}ttcher, Yvonne and Kovacs, Peter
              and Klovins, Janis and Rask-Andersen, Mathias and Schi{\"o}th,
              Helgi B",
  abstract = "BACKGROUND: The mechanisms by which genetic variants, such as
              single nucleotide polymorphisms (SNPs), identified in genome-wide
              association studies act to influence body mass remain unknown for
              most of these SNPs, which continue to puzzle the scientific
              community. Recent evidence points to the epigenetic and chromatin
              states of the genome as having important roles. METHODS: We
              genotyped 355 healthy young individuals for 52 known
              obesity-associated SNPs and obtained DNA methylation levels in
              their blood using the Illumina 450 K BeadChip. Associations
              between alleles and methylation at proximal cytosine residues
              were tested using a linear model adjusted for age, sex, weight
              category, and a proxy for blood cell type counts. For replication
              in other tissues, we used two open-access datasets (skin
              fibroblasts, n = 62; four brain regions, n = 121-133) and an
              additional dataset in subcutaneous and visceral fat (n = 149).
              RESULTS: We found that alleles at 28 of these obesity-associated
              SNPs associate with methylation levels at 107 proximal CpG sites.
              Out of 107 CpG sites, 38 are located in gene promoters, including
              genes strongly implicated in obesity (MIR148A, BDNF, PTPMT1,
              NR1H3, MGAT1, SCGB3A1, HOXC12, PMAIP1, PSIP1, RPS10-NUDT3, RPS10,
              SKOR1, MAP2K5, SIX5, AGRN, IMMP1L, ELP4, ITIH4, SEMA3G, POMC,
              ADCY3, SSPN, LGR4, TUFM, MIR4721, SULT1A1, SULT1A2, APOBR, CLN3,
              SPNS1, SH2B1, ATXN2L, and IL27). Interestingly, the associated
              SNPs are in known eQTLs for some of these genes. We also found
              that the 107 CpGs are enriched in enhancers in peripheral blood
              mononuclear cells. Finally, our results indicate that some of
              these associations are not blood-specific as we successfully
              replicated four associations in skin fibroblasts. CONCLUSIONS:
              Our results strongly suggest that many obesity-associated SNPs
              are associated with proximal gene regulation, which was reflected
              by association of obesity risk allele genotypes with differential
              DNA methylation. This study highlights the importance of DNA
              methylation and other chromatin marks as a way to understand the
              molecular basis of genetic variants associated with human
              diseases and traits.",
  journal  = "Genome Med.",
  volume   =  7,
  pages    = "103",
  month    =  oct,
  year     =  2015,
  language = "en"
}

@ARTICLE{Johansson2013-of,
  title    = "Continuous Aging of the Human {DNA} Methylome Throughout the
              Human Lifespan",
  author   = "Johansson, Asa and Enroth, Stefan and Gyllensten, Ulf",
  abstract = "DNA methylation plays an important role in development of disease
              and the process of aging. In this study we examine DNA
              methylation at 476,366 sites throughout the genome of white blood
              cells from a population cohort (N = 421) ranging in age from 14
              to 94 years old. Age affects DNA methylation at almost one third
              (29\%) of the sites (Bonferroni adjusted P-value <0.05), of which
              60.5\% becomes hypomethylated and 39.5\% hypermethylated with
              increasing age. DNA methylation sites that are located within CpG
              islands (CGIs) more often become hypermethylated compared to
              sites outside an island. CpG sites in promoters are more
              unaffected by age, whereas sites in enhancers more often becomes
              hypo- or hypermethylated. Hypermethylated sites are
              overrepresented among genes that are involved in DNA binding,
              transcription regulation, processes of anatomical structure and
              developmental process and cortex neuron differentiation (P-value
              down to P = 9.14*10(-67)). By contrast, hypomethylated sites are
              not strongly overrepresented among any biological function or
              process. Our results indicate that the 23\% of the variation in
              DNA methylation is attributed chronological age, and that
              hypermethylation is more site-specific than hypomethylation. It
              appears that the change in DNA methylation partly overlap with
              regions that change histone modifications with age, indicating an
              interaction between the two major epigenetic mechanisms.
              Epigenetic modifications and change in gene expression over time
              most likely reflects the natural process of aging and variation
              between individuals might contribute to the development of
              age-related phenotypes and diseases such as type II diabetes,
              autoimmune and cardiovascular disease.",
  journal  = "PLoS One",
  volume   =  8,
  number   =  6,
  pages    = "e67378",
  month    =  jun,
  year     =  2013,
  language = "en"
}


@ARTICLE{Schoenherr1995-fc,
  title    = "The neuron-restrictive silencer factor ({NRSF)}: a coordinate
              repressor of multiple neuron-specific genes",
  author   = "Schoenherr, C J and Anderson, D J",
  abstract = "The neuron-restrictive silencer factor (NRSF) binds a DNA
              sequence element, called the neuron-restrictive silencer element
              (NRSE), that represses neuronal gene transcription in nonneuronal
              cells. Consensus NRSEs have been identified in 18 neuron-specific
              genes. Complementary DNA clones encoding a functional fragment of
              NRSF were isolated and found to encode a novel protein containing
              eight noncanonical zinc fingers. Expression of NRSF mRNA was
              detected in most nonneuronal tissues at several developmental
              stages. In the nervous system, NRSF mRNA was detected in
              undifferentiated neuronal progenitors, but not in differentiated
              neurons. NRSF represents the first example of a vertebrate
              silencer protein that potentially regulates a large battery of
              cell type-specific genes, and therefore may function as a master
              negative regulator of neurogenesis.",
  journal  = "Science",
  volume   =  267,
  number   =  5202,
  pages    = "1360--1363",
  month    =  mar,
  year     =  1995,
  language = "en"
}

@ARTICLE{Bruce2004-je,
  title    = "Genome-wide analysis of repressor element 1 silencing
              transcription factor/neuron-restrictive silencing factor
              ({REST/NRSF}) target genes",
  author   = "Bruce, Alexander W and Donaldson, Ian J and Wood, Ian C and
              Yerbury, Sally A and Sadowski, Michael I and Chapman, Michael and
              G{\"o}ttgens, Berthold and Buckley, Noel J",
  abstract = "The completion of whole genome sequencing projects has provided
              the genetic instructions of life. However, whereas the
              identification of gene coding regions has progressed, the mapping
              of transcriptional regulatory motifs has moved more slowly. To
              understand how distinct expression profiles can be established
              and maintained, a greater understanding of these sequences and
              their trans-acting factors is required. Herein we have used a
              combined in silico and biochemical approach to identify binding
              sites [repressor element 1/neuron-restrictive silencer element
              (RE1/NRSE)] and potential target genes of RE1 silencing
              transcription factor/neuron-restrictive silencing factor
              (REST/NRSF) within the human, mouse, and Fugu rubripes genomes.
              We have used this genome-wide analysis to identify 1,892 human,
              1,894 mouse, and 554 Fugu RE1/NRSEs and present their location
              and gene linkages in a searchable database. Furthermore, we
              identified an in vivo hierarchy in which distinct subsets of
              RE1/NRSEs interact with endogenous levels of REST/NRSF, whereas
              others function as bona fide transcriptional control elements
              only in the presence of elevated levels of REST/NRSF. These data
              show that individual RE1/NRSE sites interact differentially with
              REST/NRSF within a particular cell type. This combined
              bioinformatic and biochemical approach serves to illustrate the
              selective manner in which a transcription factor interacts with
              its potential binding sites and regulates target genes. In
              addition, this approach provides a unique whole-genome map for a
              given transcription factor-binding site implicated in
              establishing specific patterns of neuronal gene expression.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  101,
  number   =  28,
  pages    = "10458--10463",
  month    =  jul,
  year     =  2004,
  language = "en"
}

@ARTICLE{Ooi2007-kk,
  title    = "Chromatin crosstalk in development and disease: lessons from
              {REST}",
  author   = "Ooi, Lezanne and Wood, Ian C",
  abstract = "Protein complexes that contain chromatin-modifying enzymes have
              an important role in regulating gene expression. Recent studies
              have shown that a single transcription factor, the repressor
              element 1-silencing transcription factor (REST), can act as a hub
              for the recruitment of multiple chromatin-modifying enzymes,
              uncovering interdependencies among individual enzymes that affect
              gene regulation. Research into the function of REST and its
              corepressors has provided novel insight into how
              chromatin-modifying proteins cooperate, and how alterations in
              this function cause disease. These mechanisms will be relevant to
              the combinatorial functioning of modular transcriptional
              regulators that work together to regulate a common promoter; they
              should also identify targets for potential therapies for a range
              of human diseases.",
  journal  = "Nat. Rev. Genet.",
  volume   =  8,
  number   =  7,
  pages    = "544--554",
  month    =  jul,
  year     =  2007,
  language = "en"
}

@ARTICLE{Bernstein2006-wt,
  title    = "A bivalent chromatin structure marks key developmental genes in
              embryonic stem cells",
  author   = "Bernstein, Bradley E and Mikkelsen, Tarjei S and Xie, Xiaohui and
              Kamal, Michael and Huebert, Dana J and Cuff, James and Fry, Ben
              and Meissner, Alex and Wernig, Marius and Plath, Kathrin and
              Jaenisch, Rudolf and Wagschal, Alexandre and Feil, Robert and
              Schreiber, Stuart L and Lander, Eric S",
  abstract = "The most highly conserved noncoding elements (HCNEs) in mammalian
              genomes cluster within regions enriched for genes encoding
              developmentally important transcription factors (TFs). This
              suggests that HCNE-rich regions may contain key regulatory
              controls involved in development. We explored this by examining
              histone methylation in mouse embryonic stem (ES) cells across 56
              large HCNE-rich loci. We identified a specific modification
              pattern, termed ``bivalent domains,'' consisting of large regions
              of H3 lysine 27 methylation harboring smaller regions of H3
              lysine 4 methylation. Bivalent domains tend to coincide with TF
              genes expressed at low levels. We propose that bivalent domains
              silence developmental genes in ES cells while keeping them poised
              for activation. We also found striking correspondences between
              genome sequence and histone methylation in ES cells, which become
              notably weaker in differentiated cells. These results highlight
              the importance of DNA sequence in defining the initial epigenetic
              landscape and suggest a novel chromatin-based mechanism for
              maintaining pluripotency.",
  journal  = "Cell",
  volume   =  125,
  number   =  2,
  pages    = "315--326",
  month    =  apr,
  year     =  2006,
  language = "en"
}

@ARTICLE{Voigt2013-fe,
  title    = "A double take on bivalent promoters",
  author   = "Voigt, Philipp and Tee, Wee-Wei and Reinberg, Danny",
  abstract = "Histone modifications and chromatin-associated protein complexes
              are crucially involved in the control of gene expression,
              supervising cell fate decisions and differentiation. Many
              promoters in embryonic stem (ES) cells harbor a distinctive
              histone modification signature that combines the activating
              histone H3 Lys 4 trimethylation (H3K4me3) mark and the repressive
              H3K27me3 mark. These bivalent domains are considered to poise
              expression of developmental genes, allowing timely activation
              while maintaining repression in the absence of differentiation
              signals. Recent advances shed light on the establishment and
              function of bivalent domains; however, their role in development
              remains controversial, not least because suitable genetic models
              to probe their function in developing organisms are missing.
              Here, we explore avenues to and from bivalency and propose that
              bivalent domains and associated chromatin-modifying complexes
              safeguard proper and robust differentiation.",
  journal  = "Genes Dev.",
  volume   =  27,
  number   =  12,
  pages    = "1318--1338",
  month    =  jun,
  year     =  2013,
  keywords = "Polycomb; Trithorax; bivalent domains; chromatin; embryonic stem
              cells",
  language = "en"
}

@ARTICLE{Ooi2007-dw,
  title    = "{DNMT3L} connects unmethylated lysine 4 of histone {H3} to de
              novo methylation of {DNA}",
  author   = "Ooi, Steen K T and Qiu, Chen and Bernstein, Emily and Li, Keqin
              and Jia, Da and Yang, Zhe and Erdjument-Bromage, Hediye and
              Tempst, Paul and Lin, Shau-Ping and Allis, C David and Cheng,
              Xiaodong and Bestor, Timothy H",
  abstract = "Mammals use DNA methylation for the heritable silencing of
              retrotransposons and imprinted genes and for the inactivation of
              the X chromosome in females. The establishment of patterns of DNA
              methylation during gametogenesis depends in part on DNMT3L, an
              enzymatically inactive regulatory factor that is related in
              sequence to the DNA methyltransferases DNMT3A and DNMT3B. The
              main proteins that interact in vivo with the product of an
              epitope-tagged allele of the endogenous Dnmt3L gene were
              identified by mass spectrometry as DNMT3A2, DNMT3B and the four
              core histones. Peptide interaction assays showed that DNMT3L
              specifically interacts with the extreme amino terminus of histone
              H3; this interaction was strongly inhibited by methylation at
              lysine 4 of histone H3 but was insensitive to modifications at
              other positions. Crystallographic studies of human DNMT3L showed
              that the protein has a carboxy-terminal methyltransferase-like
              domain and an N-terminal cysteine-rich domain. Cocrystallization
              of DNMT3L with the tail of histone H3 revealed that the tail
              bound to the cysteine-rich domain of DNMT3L, and substitution of
              key residues in the binding site eliminated the H3 tail-DNMT3L
              interaction. These data indicate that DNMT3L recognizes histone
              H3 tails that are unmethylated at lysine 4 and induces de novo
              DNA methylation by recruitment or activation of DNMT3A2.",
  journal  = "Nature",
  volume   =  448,
  number   =  7154,
  pages    = "714--717",
  month    =  aug,
  year     =  2007,
  language = "en"
}